data_1o2f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o2f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.849999999999994 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.807 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.309999999999999 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.329999999999998 108.514 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.039999999999999 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 30' ' ' ILE . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.309999999999999 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.859999999999999 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.989999999999998 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.849999999999994 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.379999999999999 107.414 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD2' HG12 ' A' ' 36' ' ' VAL . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 40' ' ' VAL . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.949999999999999 110.897 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.739999999999998 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.630000000000001 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.689999999999998 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.219999999999999 107.787 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.689999999999998 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.479999999999997 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.530000000000001 108.505 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.401 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.940000000000001 109.064 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.869999999999997 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.960000000000001 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.719999999999999 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.039999999999999 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.489999999999998 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.440000000000001 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.469999999999999 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.219999999999999 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.350000000000001 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 70' ' ' ILE . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.949999999999999 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.880000000000001 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.260000000000002 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m120 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.440000000000001 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 96' ' ' VAL . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.109999999999999 112.431 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.637 ' CB ' HD12 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.109999999999999 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.670000000000002 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.350000000000001 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.489999999999995 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.407 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.170000000000002 108.351 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.229999999999997 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.200000000000003 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.940000000000001 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.090000000000003 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.619999999999997 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.788 ' CZ ' HG22 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.539999999999999 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.689 ' C ' ' HD1' ' A' ' 90' ' ' HIS . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.050000000000001 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.489999999999998 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.210000000000001 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.030000000000001 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.059999999999999 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.030000000000001 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 98' ' ' LEU . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.649999999999999 111.279 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.489999999999998 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.109999999999999 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.629999999999999 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.190000000000001 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.940000000000001 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.399999999999999 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.009999999999998 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.090000000000003 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.550000000000001 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.568 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.030000000000001 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.300000000000001 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.620000000000001 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.239999999999998 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.649999999999999 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.229999999999997 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.870000000000001 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.690000000000001 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.550000000000001 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.079999999999998 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.850000000000001 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.780000000000001 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.8200000000000003 114.101 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.654 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.619999999999999 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.530000000000001 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.809999999999999 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.42 0.9 OUTLIER -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.340000000000003 112.716 -179.127 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.079999999999998 110.797 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.880000000000003 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.219999999999999 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.350000000000001 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.350000000000001 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.149999999999999 110.226 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.629999999999999 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.689999999999998 113.654 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.170000000000002 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.710000000000001 110.553 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.649999999999999 107.531 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.109999999999999 104.634 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.807 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.6200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 1.3600000000000001 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 1.22 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 1.21 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 1.1599999999999999 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 1.1000000000000001 108.66 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 1.1299999999999999 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 1.1200000000000001 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 1.1000000000000001 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 109.657 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.42999999999999999 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.42999999999999999 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 2.29 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.9199999999999999 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' B' ' 344' ' ' ALA . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' THR . . . . . 0.609 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 1.1499999999999999 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 2.0499999999999998 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 1.1699999999999999 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 1.0600000000000001 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' CYS . . . . . 0.487 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.40999999999999998 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' ILE . . . . . 0.788 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 1.0900000000000001 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 1.1799999999999999 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' ARG . . . . . 0.907 ' HD3' HG23 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.9900000000000002 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' LEU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 1.3100000000000001 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' ARG . . . . . 0.627 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 3.2200000000000002 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 1.0600000000000001 107.298 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' SER . . . . . 0.609 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.97999999999999998 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' B' ' 328' ' ' ASN . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 1.1699999999999999 108.511 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.8700000000000001 109.088 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 1.1799999999999999 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.99 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.6200000000000001 110.669 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 1.0700000000000001 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.1200000000000001 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 1.1799999999999999 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 1.1899999999999999 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.52000000000000002 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' LEU . . . . . 0.55 ' O ' ' HB1' ' B' ' 359' ' ' ALA . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 1.1000000000000001 108.842 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 3.2799999999999998 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' B' ' 358' ' ' GLY . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 3.1200000000000001 109.755 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 1.2 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' B' ' 356' ' ' LYS . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.58999999999999997 110.472 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' B' ' 354' ' ' LEU . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 1.1000000000000001 108.85 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 1.21 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.52000000000000002 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 1.1000000000000001 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 1.2 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 1.1699999999999999 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 1.24 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.72999999999999998 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.8999999999999999 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.56999999999999995 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 1.0900000000000001 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.74 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 1.0800000000000001 107.944 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 1.1200000000000001 109.866 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' B' ' 339' ' ' LEU . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.40999999999999998 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 1.1299999999999999 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.6400000000000001 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.6799999999999999 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.57999999999999996 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.5899999999999999 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.402 ' CD1' ' CG ' ' B' ' 373' ' ' PHE . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 1.1399999999999999 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.9199999999999999 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 1.2 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.4500000000000002 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 1.1200000000000001 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 1.0600000000000001 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.98 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.7799999999999998 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.849999999999994 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.772 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.309999999999999 110.714 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.329999999999998 108.201 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.039999999999999 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 30' ' ' ILE . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.309999999999999 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.859999999999999 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.989999999999998 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.849999999999994 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.462 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.379999999999999 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD2' HG12 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' VAL . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.949999999999999 112.756 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' N ' HG21 ' A' ' 39' ' ' VAL . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.739999999999998 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.630000000000001 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.689999999999998 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.219999999999999 107.265 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.689999999999998 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.479999999999997 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.530000000000001 110.057 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.940000000000001 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.869999999999997 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.960000000000001 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.719999999999999 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.039999999999999 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.489999999999998 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.440000000000001 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 62' ' ' PRO . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.469999999999999 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.219999999999999 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.350000000000001 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 70' ' ' ILE . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.949999999999999 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.880000000000001 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.260000000000002 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 14.4 m120 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.440000000000001 111.99 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.408 ' CE1' ' CG1' ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.109999999999999 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' CB ' ' CD1' ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.109999999999999 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.670000000000002 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.350000000000001 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.489999999999995 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.488 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.170000000000002 109.315 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.229999999999997 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.200000000000003 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.940000000000001 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' H ' ' HG ' ' A' ' 81' ' ' SER . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.090000000000003 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.619999999999997 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.539999999999999 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.585 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.050000000000001 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.489999999999998 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.210000000000001 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.030000000000001 109.56 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.408 ' CG1' ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.059999999999999 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.030000000000001 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.649999999999999 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.489999999999998 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.109999999999999 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.629999999999999 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.190000000000001 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.940000000000001 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.399999999999999 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.009999999999998 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.090000000000003 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.550000000000001 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.616 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.030000000000001 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.300000000000001 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.620000000000001 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.239999999999998 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.649999999999999 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.229999999999997 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.756 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.870000000000001 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.690000000000001 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.550000000000001 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.079999999999998 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.850000000000001 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.780000000000001 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.8200000000000003 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.619999999999999 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.530000000000001 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.809999999999999 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 143' ' ' MET . 1.5 t-20 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.340000000000003 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.079999999999998 111.985 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.880000000000003 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.219999999999999 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.350000000000001 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.350000000000001 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.149999999999999 110.139 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.629999999999999 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.689999999999998 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.170000000000002 110.212 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.710000000000001 109.566 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.649999999999999 109.45 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.109999999999999 106.597 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.772 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.6200000000000001 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 1.3600000000000001 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 1.22 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 1.21 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 1.1599999999999999 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 1.1000000000000001 108.625 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 1.1299999999999999 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 1.1000000000000001 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.443 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.42999999999999999 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.42999999999999999 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 2.29 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.9199999999999999 110.269 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 1.0900000000000001 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' THR . . . . . 0.525 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 1.1499999999999999 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 2.0499999999999998 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 1.1699999999999999 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' ALA . . . . . 0.558 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 1.0600000000000001 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.40999999999999998 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' ILE . . . . . 0.467 HD13 ' CD2' ' A' ' 90' ' ' HIS . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 1.0900000000000001 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 1.1799999999999999 111.039 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.9900000000000002 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 1.3100000000000001 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 3.2200000000000002 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 1.0600000000000001 107.473 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' SER . . . . . 0.525 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.97999999999999998 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 1.1699999999999999 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.8700000000000001 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 1.1799999999999999 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.99 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.6200000000000001 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 1.0700000000000001 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 1.1799999999999999 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 1.1899999999999999 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.52000000000000002 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' B' ' 359' ' ' ALA . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 1.1000000000000001 109.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 3.2799999999999998 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 3.1200000000000001 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 1.2 109.82 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.58999999999999997 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 354' ' ' LEU . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 1.1000000000000001 108.568 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 1.21 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.52000000000000002 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 1.1000000000000001 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 1.2 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 1.1699999999999999 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 1.24 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.72999999999999998 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.8999999999999999 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.56999999999999995 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 1.0900000000000001 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.74 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 1.0800000000000001 107.948 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 1.1200000000000001 110.274 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.40999999999999998 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' THR . . . . . 0.407 ' C ' ' H ' ' B' ' 377' ' ' SER . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 1.1299999999999999 109.918 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.6400000000000001 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' SER . . . . . 0.407 ' H ' ' C ' ' B' ' 375' ' ' THR . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.6799999999999999 109.726 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.57999999999999996 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.5899999999999999 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 1.1399999999999999 108.547 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.9199999999999999 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 1.2 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.4500000000000002 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 1.1200000000000001 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.1099999999999999 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 1.0600000000000001 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 1.1799999999999999 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.98 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.7799999999999998 109.797 -179.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.849999999999994 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.776 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 23' ' ' ILE . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.309999999999999 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.329999999999998 108.535 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.039999999999999 110.425 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 30' ' ' ILE . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.309999999999999 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.859999999999999 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.989999999999998 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.849999999999994 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.379999999999999 108.126 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' HG12 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.949999999999999 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.739999999999998 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.630000000000001 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.689999999999998 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.219999999999999 107.141 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.689999999999998 110.889 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.479999999999997 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.530000000000001 109.96 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.940000000000001 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.869999999999997 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.960000000000001 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.719999999999999 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.039999999999999 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.489999999999998 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.455 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.440000000000001 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 62' ' ' PRO . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.469999999999999 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.219999999999999 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.350000000000001 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 70' ' ' ILE . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.949999999999999 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.880000000000001 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.260000000000002 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.43 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 13.0 m120 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.440000000000001 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' CE1' ' CG1' ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.109999999999999 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.109999999999999 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.670000000000002 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.350000000000001 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.489999999999995 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.484 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.170000000000002 109.765 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.229999999999997 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.200000000000003 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.940000000000001 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' H ' ' HG ' ' A' ' 81' ' ' SER . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.090000000000003 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.619999999999997 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.539999999999999 108.759 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.651 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.050000000000001 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.489999999999998 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.210000000000001 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.030000000000001 109.213 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' GLU . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.059999999999999 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.030000000000001 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.649999999999999 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.489999999999998 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.109999999999999 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.629999999999999 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.190000000000001 110.755 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.940000000000001 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.399999999999999 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.009999999999998 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.090000000000003 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.550000000000001 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.602 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.030000000000001 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.300000000000001 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.620000000000001 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.239999999999998 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.649999999999999 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.229999999999997 107.479 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.795 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.870000000000001 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.690000000000001 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.550000000000001 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.079999999999998 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.850000000000001 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.780000000000001 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.8200000000000003 112.045 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.619999999999999 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' N ' HD11 ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.530000000000001 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.809999999999999 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 145' ' ' GLU . 1.8 t-20 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.340000000000003 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' OD1' ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.079999999999998 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.880000000000003 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.219999999999999 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 150' ' ' ILE . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.350000000000001 108.772 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.350000000000001 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.149999999999999 110.431 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.629999999999999 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.689999999999998 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.170000000000002 110.185 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.710000000000001 109.531 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.649999999999999 109.831 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.109999999999999 107.192 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.6200000000000001 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 1.3600000000000001 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 1.22 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 1.21 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 1.1599999999999999 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 1.1000000000000001 108.624 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 1.1299999999999999 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 1.1000000000000001 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28000000000000003 109.353 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.42999999999999999 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.42999999999999999 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 2.29 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.9199999999999999 110.27 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' THR . . . . . 0.49 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 1.1499999999999999 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 2.0499999999999998 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 1.1699999999999999 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' ALA . . . . . 0.548 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 1.0600000000000001 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.40999999999999998 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' ILE . . . . . 0.528 ' N ' ' SG ' ' B' ' 335' ' ' CYS . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 1.0900000000000001 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 1.1799999999999999 112.02 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.9900000000000002 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 3.2200000000000002 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 1.0600000000000001 107.434 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' SER . . . . . 0.49 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.97999999999999998 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 1.0900000000000001 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 1.1699999999999999 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.8700000000000001 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 1.1799999999999999 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.99 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.6200000000000001 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 1.0700000000000001 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.1200000000000001 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 1.1799999999999999 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 1.1899999999999999 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.52000000000000002 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 1.1000000000000001 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 3.2799999999999998 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 3.1200000000000001 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 1.2 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.58999999999999997 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 1.1000000000000001 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 1.21 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.52000000000000002 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 1.1000000000000001 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 1.2 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 1.1699999999999999 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 1.24 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.72999999999999998 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.8999999999999999 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.56999999999999995 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 1.0900000000000001 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.74 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 1.0800000000000001 107.816 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 1.1200000000000001 110.6 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.40999999999999998 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' THR . . . . . 0.423 ' C ' ' H ' ' B' ' 377' ' ' SER . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 1.1299999999999999 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.6400000000000001 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 375' ' ' THR . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.6799999999999999 109.33 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.57999999999999996 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.5899999999999999 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 1.1399999999999999 108.535 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.9199999999999999 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 1.2 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.4500000000000002 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.1099999999999999 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 1.0600000000000001 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 1.1799999999999999 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.98 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.7799999999999998 109.467 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.849999999999994 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.807 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.309999999999999 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.329999999999998 108.514 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.039999999999999 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 30' ' ' ILE . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.309999999999999 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.859999999999999 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.989999999999998 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.849999999999994 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.379999999999999 107.414 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD2' HG12 ' A' ' 36' ' ' VAL . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 40' ' ' VAL . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.949999999999999 110.897 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.907 HG23 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.739999999999998 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.630000000000001 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.689999999999998 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.219999999999999 107.787 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.689999999999998 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.479999999999997 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.530000000000001 108.505 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.401 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.940000000000001 109.064 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.869999999999997 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.960000000000001 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.719999999999999 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.039999999999999 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.489999999999998 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.440000000000001 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.469999999999999 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.219999999999999 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.350000000000001 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 70' ' ' ILE . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.949999999999999 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.880000000000001 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.260000000000002 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m120 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.440000000000001 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 96' ' ' VAL . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.109999999999999 112.431 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.637 ' CB ' HD12 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.109999999999999 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.670000000000002 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.350000000000001 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.489999999999995 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.407 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.170000000000002 108.351 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.229999999999997 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.200000000000003 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.940000000000001 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.090000000000003 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.619999999999997 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.788 ' CZ ' HG22 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.539999999999999 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.689 ' C ' ' HD1' ' A' ' 90' ' ' HIS . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.050000000000001 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.489999999999998 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.210000000000001 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.030000000000001 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.059999999999999 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.030000000000001 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 98' ' ' LEU . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.649999999999999 111.279 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.489999999999998 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.109999999999999 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.629999999999999 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.190000000000001 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.940000000000001 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.399999999999999 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.009999999999998 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.090000000000003 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.550000000000001 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.568 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.030000000000001 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.300000000000001 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.620000000000001 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.239999999999998 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.649999999999999 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.229999999999997 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.870000000000001 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.690000000000001 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.550000000000001 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.079999999999998 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.850000000000001 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.780000000000001 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.8200000000000003 114.101 -173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.654 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.619999999999999 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.530000000000001 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.809999999999999 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.42 0.9 OUTLIER -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.340000000000003 112.716 -179.127 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.079999999999998 110.797 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.880000000000003 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.219999999999999 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.350000000000001 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.350000000000001 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.149999999999999 110.226 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.629999999999999 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.689999999999998 113.654 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.170000000000002 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.710000000000001 110.553 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.649999999999999 107.531 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.109999999999999 104.634 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.807 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.6200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 1.3600000000000001 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 1.22 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 1.21 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 1.1599999999999999 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 1.1000000000000001 108.66 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 1.1299999999999999 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 1.1200000000000001 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 1.1000000000000001 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 109.657 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.42999999999999999 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.42999999999999999 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 2.29 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.9199999999999999 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' B' ' 344' ' ' ALA . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . 0.609 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 1.1499999999999999 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 2.0499999999999998 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 1.1699999999999999 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 1.0600000000000001 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' CYS . . . . . 0.487 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.40999999999999998 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' ILE . . . . . 0.788 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 1.0900000000000001 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' THR . . . . . 0.457 HG23 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 1.1799999999999999 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ARG . . . . . 0.907 ' HD3' HG23 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.9900000000000002 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' LEU . . . . . 0.515 ' HA ' ' HB3' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 1.3100000000000001 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' ARG . . . . . 0.627 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 3.2200000000000002 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 1.0600000000000001 107.298 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' SER . . . . . 0.609 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.97999999999999998 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 1.0900000000000001 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' B' ' 328' ' ' ASN . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 1.1699999999999999 108.511 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.8700000000000001 109.088 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 1.1799999999999999 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.99 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.6200000000000001 110.669 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 1.0700000000000001 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.1200000000000001 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 1.1799999999999999 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 1.1899999999999999 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.52000000000000002 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' LEU . . . . . 0.55 ' O ' ' HB1' ' B' ' 359' ' ' ALA . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 1.1000000000000001 108.842 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 3.2799999999999998 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' B' ' 358' ' ' GLY . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 3.1200000000000001 109.755 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 1.2 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' B' ' 356' ' ' LYS . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.58999999999999997 110.472 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' B' ' 354' ' ' LEU . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 1.1000000000000001 108.85 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 1.21 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.52000000000000002 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 1.1000000000000001 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 1.2 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 1.1699999999999999 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 1.24 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.72999999999999998 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.8999999999999999 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.56999999999999995 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 1.0900000000000001 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.74 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 1.0800000000000001 107.944 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 1.1200000000000001 109.866 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' PHE . . . . . 0.404 ' HE2' HD21 ' B' ' 339' ' ' LEU . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.40999999999999998 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 1.1299999999999999 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.6400000000000001 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.6799999999999999 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.57999999999999996 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.5899999999999999 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.402 ' CD1' ' CG ' ' B' ' 373' ' ' PHE . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 1.1399999999999999 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.9199999999999999 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 1.2 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.4500000000000002 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 1.1200000000000001 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 1.0600000000000001 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 1.1799999999999999 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.98 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.7799999999999998 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.849999999999994 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.772 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.309999999999999 110.714 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.329999999999998 108.201 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.039999999999999 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 30' ' ' ILE . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.309999999999999 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.859999999999999 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.989999999999998 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.849999999999994 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.462 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.379999999999999 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD2' HG12 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 40' ' ' VAL . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.949999999999999 112.756 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' N ' HG21 ' A' ' 39' ' ' VAL . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.739999999999998 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.630000000000001 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.689999999999998 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.219999999999999 107.265 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.689999999999998 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.479999999999997 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.530000000000001 110.057 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.940000000000001 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.869999999999997 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.960000000000001 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.719999999999999 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.039999999999999 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.489999999999998 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.440000000000001 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 62' ' ' PRO . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.469999999999999 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.219999999999999 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.350000000000001 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 70' ' ' ILE . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.949999999999999 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.880000000000001 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.260000000000002 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 14.4 m120 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.440000000000001 111.99 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.408 ' CE1' ' CG1' ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.109999999999999 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' CB ' ' CD1' ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.109999999999999 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.670000000000002 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.350000000000001 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.489999999999995 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.488 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.170000000000002 109.315 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.229999999999997 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.200000000000003 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.940000000000001 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' H ' ' HG ' ' A' ' 81' ' ' SER . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.090000000000003 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.619999999999997 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' CZ ' HG22 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.539999999999999 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.626 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.050000000000001 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.489999999999998 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.210000000000001 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.030000000000001 109.56 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.408 ' CG1' ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.059999999999999 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.030000000000001 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.649999999999999 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.489999999999998 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.109999999999999 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.629999999999999 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.190000000000001 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.940000000000001 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.399999999999999 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.009999999999998 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.090000000000003 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.550000000000001 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.616 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.030000000000001 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.300000000000001 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.620000000000001 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.239999999999998 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.649999999999999 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.229999999999997 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.756 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.870000000000001 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.690000000000001 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.550000000000001 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.079999999999998 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.850000000000001 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.780000000000001 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.8200000000000003 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.619999999999999 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.530000000000001 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.809999999999999 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 143' ' ' MET . 1.5 t-20 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.340000000000003 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.079999999999998 111.985 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.880000000000003 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.219999999999999 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.350000000000001 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.350000000000001 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.149999999999999 110.139 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.629999999999999 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.689999999999998 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.170000000000002 110.212 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.710000000000001 109.566 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.649999999999999 109.45 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.109999999999999 106.597 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.772 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.6200000000000001 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 1.3600000000000001 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 1.22 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 1.21 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 1.1599999999999999 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 1.1000000000000001 108.625 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 1.1299999999999999 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 1.1200000000000001 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 1.1000000000000001 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.443 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.42999999999999999 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.42999999999999999 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 2.29 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.9199999999999999 110.269 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 1.0900000000000001 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' THR . . . . . 0.525 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 1.1499999999999999 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 2.0499999999999998 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 1.1699999999999999 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' ALA . . . . . 0.558 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 1.0600000000000001 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' CYS . . . . . 0.911 ' SG ' ' P ' ' B' ' 200' ' ' PO3 . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.40999999999999998 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' ILE . . . . . 0.702 ' H ' ' P ' ' B' ' 200' ' ' PO3 . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 1.0900000000000001 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 1.1799999999999999 111.039 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.9900000000000002 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 1.3100000000000001 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 3.2200000000000002 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 1.0600000000000001 107.473 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' SER . . . . . 0.525 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.97999999999999998 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 1.1699999999999999 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.8700000000000001 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 1.1799999999999999 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.99 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.6200000000000001 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 1.0700000000000001 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 1.1799999999999999 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 1.1899999999999999 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.52000000000000002 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' LEU . . . . . 0.443 ' O ' ' HB1' ' B' ' 359' ' ' ALA . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 1.1000000000000001 109.031 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 3.2799999999999998 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 3.1200000000000001 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 1.2 109.82 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.58999999999999997 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 354' ' ' LEU . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 1.1000000000000001 108.568 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 1.21 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.52000000000000002 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 1.1000000000000001 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 1.2 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 1.1699999999999999 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 1.24 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.72999999999999998 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.8999999999999999 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.56999999999999995 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 1.0900000000000001 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.74 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 1.0800000000000001 107.948 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 1.1200000000000001 110.274 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.40999999999999998 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' THR . . . . . 0.407 ' C ' ' H ' ' B' ' 377' ' ' SER . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 1.1299999999999999 109.918 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.6400000000000001 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' SER . . . . . 0.407 ' H ' ' C ' ' B' ' 375' ' ' THR . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.6799999999999999 109.726 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.57999999999999996 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.5899999999999999 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 1.1399999999999999 108.547 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.9199999999999999 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 1.2 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.4500000000000002 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 1.1200000000000001 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.1099999999999999 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 1.0600000000000001 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 1.1799999999999999 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.98 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.7799999999999998 109.797 -179.363 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . 0.911 ' P ' ' SG ' ' B' ' 335' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.849999999999994 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.776 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 23' ' ' ILE . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.309999999999999 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.329999999999998 108.535 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.039999999999999 110.425 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 30' ' ' ILE . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.309999999999999 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.859999999999999 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.989999999999998 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.849999999999994 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.379999999999999 108.126 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' HG12 ' A' ' 36' ' ' VAL . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.949999999999999 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.739999999999998 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.630000000000001 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.689999999999998 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.219999999999999 107.141 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.689999999999998 110.889 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.479999999999997 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.530000000000001 109.96 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.940000000000001 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.869999999999997 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.960000000000001 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.719999999999999 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.039999999999999 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.489999999999998 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' O ' ' CG1' ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.440000000000001 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 62' ' ' PRO . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.469999999999999 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.219999999999999 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.350000000000001 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 70' ' ' ILE . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.949999999999999 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.880000000000001 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.260000000000002 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.43 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 13.0 m120 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.440000000000001 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' CE1' ' CG1' ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.109999999999999 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.109999999999999 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.670000000000002 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.350000000000001 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.489999999999995 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.484 ' HG ' ' H ' ' A' ' 85' ' ' VAL . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.170000000000002 109.765 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.229999999999997 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.200000000000003 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.940000000000001 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' H ' ' HG ' ' A' ' 81' ' ' SER . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.090000000000003 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.619999999999997 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.539999999999999 108.759 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 1.256 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.050000000000001 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.489999999999998 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.210000000000001 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.030000000000001 109.213 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' GLU . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.059999999999999 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.030000000000001 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.649999999999999 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.489999999999998 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.109999999999999 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.629999999999999 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.190000000000001 110.755 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.940000000000001 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.399999999999999 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.009999999999998 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.090000000000003 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.550000000000001 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.602 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.030000000000001 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.300000000000001 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.620000000000001 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.239999999999998 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.649999999999999 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.229999999999997 107.479 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.795 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.870000000000001 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.690000000000001 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.550000000000001 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.079999999999998 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.850000000000001 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.780000000000001 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.8200000000000003 112.045 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.619999999999999 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' N ' HD11 ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.530000000000001 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.809999999999999 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 145' ' ' GLU . 1.8 t-20 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.340000000000003 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.401 ' HB2' ' OD1' ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.079999999999998 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.880000000000003 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.219999999999999 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 150' ' ' ILE . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.350000000000001 108.772 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.350000000000001 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.149999999999999 110.431 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.629999999999999 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.689999999999998 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.170000000000002 110.185 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.710000000000001 109.531 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.649999999999999 109.831 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.109999999999999 107.192 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.776 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.6200000000000001 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 1.3600000000000001 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 1.22 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 1.21 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 1.1599999999999999 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 1.1000000000000001 108.624 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 1.1299999999999999 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 1.1000000000000001 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28000000000000003 109.353 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.42999999999999999 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.42999999999999999 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 2.29 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.9199999999999999 110.27 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' THR . . . . . 0.49 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 1.1499999999999999 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 2.0499999999999998 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 1.1699999999999999 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' ALA . . . . . 0.548 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 1.0600000000000001 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.40999999999999998 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' ILE . . . . . 0.677 ' H ' ' P ' ' B' ' 200' ' ' PO3 . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 1.0900000000000001 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 1.1799999999999999 112.02 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.9900000000000002 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 3.2200000000000002 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 1.0600000000000001 107.434 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' SER . . . . . 0.49 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.97999999999999998 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 1.0900000000000001 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 1.1699999999999999 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.8700000000000001 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 1.1799999999999999 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.99 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.6200000000000001 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 1.0700000000000001 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.1200000000000001 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 1.1799999999999999 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 1.1899999999999999 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.52000000000000002 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 1.1000000000000001 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 3.2799999999999998 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 3.1200000000000001 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 1.2 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.58999999999999997 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 1.1000000000000001 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 1.21 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.52000000000000002 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 1.1000000000000001 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 1.2 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 1.1699999999999999 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 1.24 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.72999999999999998 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.8999999999999999 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.56999999999999995 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 1.0900000000000001 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.74 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' ALA . . . . . . . . . . . . . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 1.0800000000000001 107.816 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' ILE . . . . . . . . . . . . . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 1.1200000000000001 110.6 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.40999999999999998 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' THR . . . . . 0.423 ' C ' ' H ' ' B' ' 377' ' ' SER . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 1.1299999999999999 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.6400000000000001 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 375' ' ' THR . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.6799999999999999 109.33 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.57999999999999996 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.5899999999999999 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 1.1399999999999999 108.535 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.9199999999999999 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 1.2 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.4500000000000002 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.1099999999999999 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 1.0600000000000001 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 1.1799999999999999 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.98 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.7799999999999998 109.467 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . 1.256 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.85 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.31 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.33 108.514 173.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.04 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.31 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.86 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.99 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.85 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.38 107.414 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.95 110.897 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.74 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.63 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.69 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.618 HG21 HG21 ' B' ' 372' ' ' ILE . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.22 107.787 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.69 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.48 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.53 108.505 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.94 109.064 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.87 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.96 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.72 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.04 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.49 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.44 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 115' ' ' VAL . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.9 ' OD1' HG23 ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.47 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.22 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.35 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.95 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.88 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.26 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.44 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.11 112.431 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.11 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.67 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.35 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.49 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.17 108.351 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.23 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.2 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.94 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.09 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.62 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.54 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.708 ' CD2' HD12 ' B' ' 336' ' ' ILE . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.05 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.49 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.21 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.03 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.06 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.677 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.03 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.65 111.279 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.49 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.11 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.63 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.19 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.94 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.4 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.01 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.09 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.55 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.9 HG23 ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.03 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.3 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.62 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.24 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.65 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.23 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.721 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.87 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.69 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.55 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.08 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.85 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.78 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 26' ' ' LEU . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.82 114.101 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.62 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.53 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.81 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.42 43.1 t30 -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.34 112.716 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.08 110.797 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.88 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.22 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.35 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.35 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 163' ' ' VAL . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.15 110.226 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.63 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 156' ' ' VAL . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.69 113.654 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.17 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 156' ' ' VAL . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.71 110.553 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 165' ' ' ARG . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.65 107.531 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.11 104.634 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.825 HD11 HG21 ' A' ' 85' ' ' VAL . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.62 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 0.7 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 0.56 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.59 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 0.5 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 319' ' ' LEU . . . . . 0.64 ' CD1' HD22 ' B' ' 380' ' ' LEU . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.38 108.66 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 0.39 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 0.44 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.34 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 323' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' B' ' 341' ' ' VAL . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28 109.657 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.43 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.4 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 1.88 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.92 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 0.4 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.608 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 0.51 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 331' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 1.7 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 0.35 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 335' ' ' CYS . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.41 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' ILE . . . . . 0.737 HG21 ' CE1' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 0.46 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 337' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 0.56 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 338' ' ' ARG . . . . . 0.581 ' HD3' HG22 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.48 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 339' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.61 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 340' ' ' ARG . . . . . 0.677 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 2.59 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' B' ' 323' ' ' PHE . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 0.27 107.298 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 342' ' ' SER . . . . . 0.608 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.4 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 0.42 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 0.48 108.511 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 345' ' ' ASP . . . . . 0.461 ' HB3' ' HG3' ' B' ' 348' ' ' LYS . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.87 109.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 0.5 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.46 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 348' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' B' ' 345' ' ' ASP . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.16 110.669 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 0.38 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.12 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 0.78 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 0.58 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.48 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 0.43 108.842 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 2.87 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 2.63 109.755 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 0.56 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.55 110.472 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 0.49 108.85 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 0.61 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.48 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 0.44 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 0.51 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 0.59 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 0.63 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.69 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.42 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.53 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 0.37 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.38 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 371' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 0.24 107.944 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 372' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 45' ' ' ILE . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.4 109.866 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 373' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.38 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.46 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.16 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.26 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.58 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.02 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.64 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 0.43 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.42 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.6 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.45 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 0.51 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.11 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 0.67 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.67 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.36 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.18 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.85 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.783 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.31 110.714 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.561 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.33 108.201 175.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.04 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.31 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.86 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.99 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.85 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.38 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 40' ' ' VAL . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.95 112.756 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' B' ' 338' ' ' ARG . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.74 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.63 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.69 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HG21 ' B' ' 372' ' ' ILE . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.22 107.265 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.69 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.48 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.58 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.53 110.057 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.537 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.94 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.87 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.96 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.72 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.04 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.49 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' C ' HG13 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.44 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 115' ' ' VAL . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.841 ' OD1' HG23 ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.47 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.22 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.35 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.95 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.88 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.26 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.44 111.99 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.431 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.11 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.11 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.67 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.35 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.49 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.17 109.315 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.23 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.2 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.94 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 166' ' ' ILE . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.09 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.62 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.54 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.845 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.05 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.49 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.21 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 93' ' ' ILE . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.03 109.56 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.06 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.03 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.65 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.49 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.11 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.63 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.19 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.94 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.4 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.01 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.09 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.55 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.841 HG23 ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.03 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.3 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.62 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.24 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.65 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.23 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.87 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.69 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.55 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.08 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.85 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.78 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 135' ' ' LEU . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.82 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.62 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.53 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.81 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 145' ' ' GLU . 57.8 t30 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.34 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.08 111.985 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.88 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.22 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.35 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 152' ' ' LEU . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.35 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.668 HG11 HG12 ' A' ' 163' ' ' VAL . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.15 110.139 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.63 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.69 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.17 110.212 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.668 HG12 HG11 ' A' ' 156' ' ' VAL . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.71 109.566 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 165' ' ' ARG . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.65 109.45 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.11 106.597 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 85' ' ' VAL . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.62 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 0.7 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 0.56 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 0.59 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 0.5 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 319' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' B' ' 380' ' ' LEU . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 0.38 108.625 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 0.39 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 0.44 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 0.34 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 323' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28 109.443 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.43 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.4 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 1.88 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 327' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.92 110.269 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 0.4 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.5 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 0.51 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 1.7 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 0.51 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 334' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 0.35 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 335' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.41 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' ILE . . . . . 0.845 HD12 ' CD2' ' A' ' 90' ' ' HIS . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 0.46 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 337' ' ' THR . . . . . 0.62 HG21 ' HB ' ' A' ' 46' ' ' VAL . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 0.56 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.48 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 339' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.61 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 2.59 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 341' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 0.27 107.473 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 342' ' ' SER . . . . . 0.5 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.4 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.42 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 0.48 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.87 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.5 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.46 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.16 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 0.38 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.12 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 0.78 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 0.58 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.48 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 0.43 109.031 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 2.87 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 2.63 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' B' ' 357' ' ' LEU . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 0.56 109.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.55 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 0.49 108.568 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 0.61 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.48 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 0.44 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 0.51 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 0.59 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.69 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.42 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.53 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 0.37 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.38 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 0.24 107.948 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 372' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 45' ' ' ILE . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 0.4 110.274 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 373' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.38 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 0.46 109.918 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.16 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.26 109.726 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.58 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.02 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 0.43 108.547 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.42 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.6 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.45 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 0.51 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.11 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 0.67 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 0.67 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.36 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.18 109.797 -179.363 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.85 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.786 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.31 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.33 108.535 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 53' ' ' LYS . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.04 110.425 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.31 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.86 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.99 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.85 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.38 108.126 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.95 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.74 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.63 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.69 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.513 HG21 HG21 ' B' ' 372' ' ' ILE . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.22 107.141 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 337' ' ' THR . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.69 110.889 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.48 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.53 109.96 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.94 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.87 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.96 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.72 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.04 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.49 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.44 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 115' ' ' VAL . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.791 ' OD1' HG23 ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.47 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.22 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.35 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.449 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.95 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.88 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.26 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 16.9 m-80 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.44 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.11 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.11 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.67 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.35 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.49 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.17 109.765 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.23 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.2 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.94 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 166' ' ' ILE . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.09 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.62 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' B' ' 336' ' ' ILE . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.54 108.759 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.732 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.05 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.49 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.21 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 93' ' ' ILE . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.03 109.213 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 75' ' ' HIS . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.06 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.03 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.65 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.49 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.11 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.63 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.19 110.755 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.557 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.94 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.4 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.01 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.09 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.55 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.791 HG23 ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.03 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.3 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.62 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.24 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.65 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.23 107.479 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.805 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.87 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.089 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.69 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.55 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.08 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.85 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.78 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.474 HG21 HD21 ' A' ' 26' ' ' LEU . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.82 112.045 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.62 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.53 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.81 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 145' ' ' GLU . 62.4 t30 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.34 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.08 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.524 ' O ' HG13 ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.88 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.22 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.35 108.772 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 152' ' ' LEU . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.35 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.672 HG11 HG12 ' A' ' 163' ' ' VAL . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.15 110.431 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.63 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.69 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.17 110.185 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG11 ' A' ' 156' ' ' VAL . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.71 109.531 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' ARG . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.65 109.831 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.403 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.11 107.192 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.786 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.62 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 0.7 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 0.56 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 0.59 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 0.5 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 319' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' B' ' 380' ' ' LEU . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 0.38 108.624 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.39 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.44 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.34 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28 109.353 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.43 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.4 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 1.88 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 327' ' ' GLU . . . . . 0.463 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.92 110.27 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.4 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.463 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 0.51 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 1.7 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 0.51 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 334' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 0.35 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.41 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' ILE . . . . . 0.732 HD12 ' CD2' ' A' ' 90' ' ' HIS . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 0.46 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 337' ' ' THR . . . . . 0.591 HG21 ' HB ' ' A' ' 46' ' ' VAL . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 0.56 112.02 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.48 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 339' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 0.61 107.754 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 2.59 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 341' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 0.27 107.434 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 342' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.4 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.42 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 0.48 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.87 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.5 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.46 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.16 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 0.38 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.12 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 0.78 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.58 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.48 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 0.43 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 2.87 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 2.63 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 0.56 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.55 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 0.49 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 0.61 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.48 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 0.44 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 0.51 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 0.59 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.63 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.69 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.42 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.53 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 0.37 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.38 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 0.24 107.816 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' ILE . . . . . 0.513 HG21 HG21 ' A' ' 45' ' ' ILE . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.4 110.6 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 373' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.38 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 375' ' ' THR . . . . . 0.442 ' HA ' HG22 ' B' ' 337' ' ' THR . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 0.46 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.16 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.26 109.33 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.58 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.02 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.43 108.535 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.42 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 0.6 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.45 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 0.51 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.11 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 0.67 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 0.67 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.36 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.18 109.467 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.85 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.31 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.33 108.514 173.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.04 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.31 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.86 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.99 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.85 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.38 107.414 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.95 110.897 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.74 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.63 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.69 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.618 HG21 HG21 ' B' ' 372' ' ' ILE . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.22 107.787 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.69 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.48 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.53 108.505 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.94 109.064 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.87 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.96 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.72 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.04 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.49 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.44 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 115' ' ' VAL . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.9 ' OD1' HG23 ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.47 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.22 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.35 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.95 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.88 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.26 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.44 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.11 112.431 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.11 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.67 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.35 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.49 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.17 108.351 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.23 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.2 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.94 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.09 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.62 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.54 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.708 ' CD2' HD12 ' B' ' 336' ' ' ILE . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.05 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.49 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.21 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.03 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.06 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.677 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.03 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.65 111.279 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.49 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.11 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.63 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.19 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.94 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.4 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.01 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.09 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.55 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.9 HG23 ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.03 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.3 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.62 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.24 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.65 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.23 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.721 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.87 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.69 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.55 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.08 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.85 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.78 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 26' ' ' LEU . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.82 114.101 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.62 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.53 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.81 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.42 43.1 t30 -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.34 112.716 -179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.08 110.797 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.88 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.22 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.35 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.35 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 163' ' ' VAL . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.15 110.226 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.63 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 156' ' ' VAL . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.69 113.654 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.17 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 156' ' ' VAL . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.71 110.553 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 165' ' ' ARG . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.65 107.531 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.11 104.634 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.825 HD11 HG21 ' A' ' 85' ' ' VAL . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.62 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 0.7 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 0.56 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.59 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 0.5 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' LEU . . . . . 0.64 ' CD1' HD22 ' B' ' 380' ' ' LEU . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.38 108.66 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 0.39 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 0.44 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.34 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' B' ' 341' ' ' VAL . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28 109.657 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.43 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.4 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 1.88 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.92 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 0.4 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.608 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 0.51 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 1.7 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 0.35 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 335' ' ' CYS . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.41 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' ILE . . . . . 0.737 HG21 ' CE1' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 0.46 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 337' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 0.56 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ARG . . . . . 0.581 ' HD3' HG22 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.48 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 339' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.61 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 340' ' ' ARG . . . . . 0.677 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 2.59 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' B' ' 323' ' ' PHE . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 0.27 107.298 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' SER . . . . . 0.608 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.4 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 0.42 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 0.48 108.511 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' ASP . . . . . 0.461 ' HB3' ' HG3' ' B' ' 348' ' ' LYS . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.87 109.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 0.5 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.46 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' B' ' 345' ' ' ASP . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.16 110.669 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 0.38 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.12 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 0.78 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 0.58 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.48 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 0.43 108.842 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 2.87 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 2.63 109.755 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 0.56 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.55 110.472 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 0.49 108.85 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 0.61 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.48 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 0.44 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 0.51 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 0.59 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 0.63 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.69 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.42 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.53 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 0.37 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.38 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 0.24 107.944 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 45' ' ' ILE . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.4 109.866 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.38 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.46 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.16 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.26 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.58 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.02 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.64 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 0.43 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.42 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.6 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.45 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 0.51 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.11 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 0.67 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.67 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.36 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.18 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.85 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.783 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.31 110.714 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.561 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.33 108.201 175.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.04 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.31 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.86 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.99 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.85 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.38 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 40' ' ' VAL . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.95 112.756 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' B' ' 338' ' ' ARG . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.74 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.63 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.69 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HG21 ' B' ' 372' ' ' ILE . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.22 107.265 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.69 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.48 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.58 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.53 110.057 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.537 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.94 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.87 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.96 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.72 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.04 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.49 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' C ' HG13 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.44 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 115' ' ' VAL . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.841 ' OD1' HG23 ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.47 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.22 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.35 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.95 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.88 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.26 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.44 111.99 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.431 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.11 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.11 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.67 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.35 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.49 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.17 109.315 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.23 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.2 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.94 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 166' ' ' ILE . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.09 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.62 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.54 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.845 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.05 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.49 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.21 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 93' ' ' ILE . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.03 109.56 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.06 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.03 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.65 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.49 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.11 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.63 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.19 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.94 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.4 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.01 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.09 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.55 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.841 HG23 ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.03 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.3 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.62 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.24 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.65 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.23 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.87 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.69 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.55 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.08 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.85 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.78 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 135' ' ' LEU . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.82 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.62 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.53 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.81 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 145' ' ' GLU . 57.8 t30 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.34 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.08 111.985 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.88 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.22 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.35 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 152' ' ' LEU . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.35 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.668 HG11 HG12 ' A' ' 163' ' ' VAL . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.15 110.139 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.63 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.69 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.17 110.212 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.668 HG12 HG11 ' A' ' 156' ' ' VAL . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.71 109.566 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 165' ' ' ARG . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.65 109.45 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.11 106.597 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 85' ' ' VAL . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.62 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 0.7 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 0.56 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 0.59 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 0.5 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' B' ' 380' ' ' LEU . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 0.38 108.625 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 0.39 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 0.44 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 0.34 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28 109.443 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.43 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.4 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 1.88 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.92 110.269 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 0.4 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.5 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 0.51 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 1.7 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 0.51 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 334' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 0.35 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 335' ' ' CYS . . . . . 0.911 ' SG ' ' P ' ' B' ' 200' ' ' PO3 . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.41 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' ILE . . . . . 0.845 HD12 ' CD2' ' A' ' 90' ' ' HIS . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 0.46 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 337' ' ' THR . . . . . 0.62 HG21 ' HB ' ' A' ' 46' ' ' VAL . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 0.56 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.48 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 339' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.61 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 2.59 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 0.27 107.473 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 342' ' ' SER . . . . . 0.5 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.4 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.42 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 0.48 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.87 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.5 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.46 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.16 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 0.38 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.12 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 0.78 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 0.58 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.48 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 0.43 109.031 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 2.87 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 2.63 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' B' ' 357' ' ' LEU . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 0.56 109.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.55 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 0.49 108.568 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 0.61 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.48 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 0.44 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 0.51 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 0.59 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.69 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.42 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.53 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 0.37 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.38 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 0.24 107.948 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 45' ' ' ILE . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 0.4 110.274 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.38 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 0.46 109.918 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.16 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.26 109.726 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.58 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.02 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 0.43 108.547 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.42 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.6 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.45 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 0.51 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.11 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 0.67 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 0.67 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.36 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.18 109.797 -179.363 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . 0.911 ' P ' ' SG ' ' B' ' 335' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.85 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.786 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.31 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.33 108.535 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 53' ' ' LYS . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.04 110.425 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.31 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.86 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.99 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.85 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.38 108.126 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.95 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.74 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.63 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.69 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.513 HG21 HG21 ' B' ' 372' ' ' ILE . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.22 107.141 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 337' ' ' THR . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.69 110.889 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.48 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.53 109.96 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.94 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.87 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.96 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.72 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.04 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.49 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.44 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 115' ' ' VAL . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.791 ' OD1' HG23 ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.47 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.22 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.35 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.449 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.95 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.88 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.26 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 16.9 m-80 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.44 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.11 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.11 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.67 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.35 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.49 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.17 109.765 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.23 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.2 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.94 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 166' ' ' ILE . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.09 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.62 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' B' ' 336' ' ' ILE . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.54 108.759 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 1.256 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.05 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.49 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.21 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 93' ' ' ILE . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.03 109.213 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 75' ' ' HIS . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.06 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.03 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.65 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.49 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.11 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.63 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.19 110.755 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.557 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.94 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.4 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.01 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.09 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.55 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.791 HG23 ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.03 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.3 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.62 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.24 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.65 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.23 107.479 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.805 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.87 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.089 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.69 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.55 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.08 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.85 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.78 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.474 HG21 HD21 ' A' ' 26' ' ' LEU . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.82 112.045 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.62 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.53 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.81 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 145' ' ' GLU . 62.4 t30 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.34 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.08 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.524 ' O ' HG13 ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.88 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.22 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.35 108.772 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 152' ' ' LEU . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.35 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.672 HG11 HG12 ' A' ' 163' ' ' VAL . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.15 110.431 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.63 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.69 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.17 110.185 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG11 ' A' ' 156' ' ' VAL . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.71 109.531 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' ARG . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.65 109.831 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.403 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.11 107.192 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.786 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.62 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 0.7 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 0.56 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 0.59 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 0.5 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' B' ' 380' ' ' LEU . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 0.38 108.624 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.39 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.44 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.34 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28 109.353 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.43 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.4 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 1.88 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 327' ' ' GLU . . . . . 0.463 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.92 110.27 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.4 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.463 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 0.51 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 1.7 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 0.51 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 334' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 0.35 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.41 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' ILE . . . . . 0.732 HD12 ' CD2' ' A' ' 90' ' ' HIS . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 0.46 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 337' ' ' THR . . . . . 0.591 HG21 ' HB ' ' A' ' 46' ' ' VAL . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 0.56 112.02 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.48 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 339' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 0.61 107.754 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 2.59 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 341' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 0.27 107.434 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 342' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.4 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.42 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 0.48 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.87 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.5 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.46 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.16 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 0.38 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.12 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 0.78 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.58 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.48 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 0.43 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 2.87 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 2.63 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 0.56 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.55 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 0.49 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 0.61 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.48 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 0.44 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 0.51 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 0.59 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.63 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.69 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.42 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.53 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 0.37 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.38 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 0.24 107.816 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' ILE . . . . . 0.513 HG21 HG21 ' A' ' 45' ' ' ILE . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.4 110.6 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.38 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' THR . . . . . 0.442 ' HA ' HG22 ' B' ' 337' ' ' THR . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 0.46 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.16 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.26 109.33 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.58 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.02 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.43 108.535 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.42 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 0.6 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.45 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 0.51 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.11 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 0.67 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 0.67 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.36 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.18 109.467 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . 1.256 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.849999999999994 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.309999999999999 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.329999999999998 108.514 173.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.039999999999999 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.309999999999999 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.859999999999999 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.989999999999998 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.849999999999994 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.379999999999999 107.414 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.949999999999999 110.897 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.739999999999998 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.630000000000001 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.689999999999998 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.618 HG21 HG21 ' B' ' 372' ' ' ILE . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.219999999999999 107.787 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.689999999999998 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.479999999999997 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.530000000000001 108.505 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.940000000000001 109.064 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.869999999999997 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.960000000000001 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.719999999999999 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.039999999999999 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.489999999999998 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.440000000000001 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 115' ' ' VAL . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.9 ' OD1' HG23 ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.469999999999999 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.219999999999999 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.350000000000001 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.949999999999999 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.880000000000001 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.260000000000002 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m120 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.440000000000001 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.109999999999999 112.431 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.109999999999999 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.670000000000002 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.350000000000001 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.489999999999995 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.170000000000002 108.351 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.229999999999997 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.200000000000003 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.940000000000001 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.090000000000003 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.619999999999997 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.539999999999999 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.708 ' CD2' HD12 ' B' ' 336' ' ' ILE . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.050000000000001 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.489999999999998 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.210000000000001 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.030000000000001 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.059999999999999 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.677 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.030000000000001 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.649999999999999 111.279 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.489999999999998 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.109999999999999 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.629999999999999 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.190000000000001 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.940000000000001 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.399999999999999 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.009999999999998 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.090000000000003 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.550000000000001 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.9 HG23 ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.030000000000001 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.300000000000001 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.620000000000001 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.239999999999998 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.649999999999999 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.229999999999997 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.721 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.870000000000001 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.690000000000001 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.550000000000001 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.079999999999998 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.850000000000001 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.780000000000001 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 26' ' ' LEU . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.8200000000000003 114.101 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.619999999999999 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.530000000000001 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.809999999999999 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.518 HD21 ' CD ' ' A' ' 145' ' ' GLU 0.42 0.9 OUTLIER -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.340000000000003 112.716 -179.127 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.518 ' CD ' HD21 ' A' ' 142' ' ' ASN . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.079999999999998 110.797 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.880000000000003 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.219999999999999 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.350000000000001 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.350000000000001 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 163' ' ' VAL . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.149999999999999 110.226 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.629999999999999 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 156' ' ' VAL . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.689999999999998 113.654 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.170000000000002 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 156' ' ' VAL . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.710000000000001 110.553 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 165' ' ' ARG . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.649999999999999 107.531 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.109999999999999 104.634 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.825 HD11 HG21 ' A' ' 85' ' ' VAL . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.6200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 0.69999999999999996 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 0.56000000000000005 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.58999999999999997 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 0.5 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' LEU . . . . . 0.64 ' CD1' HD22 ' B' ' 380' ' ' LEU . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.38 108.66 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 0.39000000000000001 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 0.44 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.34000000000000002 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' B' ' 341' ' ' VAL . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 109.657 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.42999999999999999 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.40000000000000002 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 1.8799999999999999 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.9199999999999999 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 0.40000000000000002 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.608 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 0.51000000000000001 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 1.7 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 0.51000000000000001 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 0.34999999999999998 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' CYS . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.40999999999999998 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' ILE . . . . . 0.737 HG21 ' CE1' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 0.46000000000000002 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 0.56000000000000005 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' ARG . . . . . 0.581 ' HD3' HG22 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.48 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.60999999999999999 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' ARG . . . . . 0.677 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 2.5899999999999999 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' B' ' 323' ' ' PHE . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 0.27000000000000002 107.298 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' SER . . . . . 0.608 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.40000000000000002 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 0.41999999999999998 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 0.47999999999999998 108.511 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' ASP . . . . . 0.461 ' HB3' ' HG3' ' B' ' 348' ' ' LYS . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.8700000000000001 109.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 0.5 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.46 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' B' ' 345' ' ' ASP . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.1600000000000001 110.669 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 0.38 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.1200000000000001 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 0.78000000000000003 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.47999999999999998 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 0.42999999999999999 108.842 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 2.8700000000000001 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 2.6299999999999999 109.755 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 0.56000000000000005 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.55000000000000004 110.472 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 0.48999999999999999 108.85 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 0.60999999999999999 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.47999999999999998 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 0.44 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 0.51000000000000001 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 0.58999999999999997 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 0.63 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.68999999999999995 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.4199999999999999 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.53000000000000003 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 0.37 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.3799999999999999 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 0.23999999999999999 107.944 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 45' ' ' ILE . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.40000000000000002 109.866 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.38 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.46000000000000002 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.1600000000000001 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.26 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.57999999999999996 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.02 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.64 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 0.42999999999999999 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.4199999999999999 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.59999999999999998 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.4500000000000002 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 0.51000000000000001 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 0.67000000000000004 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.67000000000000004 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.3599999999999999 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.1800000000000002 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.849999999999994 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.783 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.309999999999999 110.714 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.561 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.329999999999998 108.201 175.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.039999999999999 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.309999999999999 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.859999999999999 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.989999999999998 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.849999999999994 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.379999999999999 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 40' ' ' VAL . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.949999999999999 112.756 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' B' ' 338' ' ' ARG . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.739999999999998 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.630000000000001 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.689999999999998 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HG21 ' B' ' 372' ' ' ILE . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.219999999999999 107.265 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.689999999999998 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.479999999999997 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.58 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.530000000000001 110.057 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.537 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.940000000000001 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.869999999999997 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.960000000000001 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.719999999999999 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.039999999999999 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.489999999999998 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' C ' HG13 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.440000000000001 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 115' ' ' VAL . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.841 ' OD1' HG23 ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.469999999999999 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.219999999999999 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.350000000000001 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.949999999999999 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.880000000000001 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.260000000000002 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 14.4 m120 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.440000000000001 111.99 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.431 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.109999999999999 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.109999999999999 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.670000000000002 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.350000000000001 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.489999999999995 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.170000000000002 109.315 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.229999999999997 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.200000000000003 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.940000000000001 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 166' ' ' ILE . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.090000000000003 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.596 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.619999999999997 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.539999999999999 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.845 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.050000000000001 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.489999999999998 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.210000000000001 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 93' ' ' ILE . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.030000000000001 109.56 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.059999999999999 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.030000000000001 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.649999999999999 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.489999999999998 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.109999999999999 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.629999999999999 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.190000000000001 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.940000000000001 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.399999999999999 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.009999999999998 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.090000000000003 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.550000000000001 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.841 HG23 ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.030000000000001 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.300000000000001 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.620000000000001 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.239999999999998 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.649999999999999 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.229999999999997 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.870000000000001 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.690000000000001 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.550000000000001 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.079999999999998 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.850000000000001 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.780000000000001 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 135' ' ' LEU . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.8200000000000003 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.619999999999999 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.530000000000001 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.809999999999999 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.615 HD21 ' CD ' ' A' ' 145' ' ' GLU . 1.5 t-20 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.340000000000003 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.615 ' CD ' HD21 ' A' ' 142' ' ' ASN . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.079999999999998 111.985 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.880000000000003 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.219999999999999 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.350000000000001 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 152' ' ' LEU . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.350000000000001 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.668 HG11 HG12 ' A' ' 163' ' ' VAL . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.149999999999999 110.139 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.629999999999999 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.689999999999998 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.170000000000002 110.212 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.668 HG12 HG11 ' A' ' 156' ' ' VAL . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.710000000000001 109.566 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 165' ' ' ARG . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.649999999999999 109.45 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.109999999999999 106.597 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 85' ' ' VAL . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.6200000000000001 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 0.69999999999999996 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 0.56000000000000005 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 0.58999999999999997 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 0.5 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' B' ' 380' ' ' LEU . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 0.38 108.625 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 0.39000000000000001 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 0.44 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 0.34000000000000002 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.443 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.42999999999999999 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.40000000000000002 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 1.8799999999999999 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.9199999999999999 110.269 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 0.40000000000000002 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.5 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 0.51000000000000001 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 1.7 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 0.51000000000000001 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 0.34999999999999998 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.40999999999999998 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' ILE . . . . . 0.845 HD12 ' CD2' ' A' ' 90' ' ' HIS . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 0.46000000000000002 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' THR . . . . . 0.62 HG21 ' HB ' ' A' ' 46' ' ' VAL . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 0.56000000000000005 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.48 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.60999999999999999 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 2.5899999999999999 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 0.27000000000000002 107.473 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' SER . . . . . 0.5 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.40000000000000002 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 0.47999999999999998 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.8700000000000001 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.5 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.46 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.1600000000000001 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 0.38 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 0.78000000000000003 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 0.57999999999999996 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.47999999999999998 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 0.42999999999999999 109.031 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 2.8700000000000001 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 2.6299999999999999 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' B' ' 357' ' ' LEU . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 0.56000000000000005 109.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.55000000000000004 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 0.48999999999999999 108.568 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 0.60999999999999999 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.47999999999999998 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 0.44 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 0.51000000000000001 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 0.58999999999999997 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.68999999999999995 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.4199999999999999 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.53000000000000003 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 0.37 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.3799999999999999 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 0.23999999999999999 107.948 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 45' ' ' ILE . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 0.40000000000000002 110.274 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.38 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 0.46000000000000002 109.918 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.1600000000000001 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.26 109.726 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.57999999999999996 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.02 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 0.42999999999999999 108.547 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.4199999999999999 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.59999999999999998 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.4500000000000002 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.1099999999999999 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 0.67000000000000004 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 0.67000000000000004 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.3599999999999999 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.1800000000000002 109.797 -179.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.849999999999994 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.786 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.309999999999999 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.329999999999998 108.535 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 53' ' ' LYS . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.039999999999999 110.425 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.309999999999999 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.859999999999999 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.989999999999998 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.849999999999994 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.379999999999999 108.126 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.949999999999999 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.739999999999998 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.630000000000001 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.689999999999998 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.513 HG21 HG21 ' B' ' 372' ' ' ILE . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.219999999999999 107.141 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 337' ' ' THR . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.689999999999998 110.889 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.479999999999997 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.530000000000001 109.96 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.940000000000001 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.869999999999997 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.960000000000001 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.719999999999999 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.039999999999999 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.489999999999998 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.440000000000001 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 115' ' ' VAL . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.791 ' OD1' HG23 ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.469999999999999 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.219999999999999 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.350000000000001 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.449 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.949999999999999 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.880000000000001 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.260000000000002 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 13.0 m120 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.440000000000001 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.109999999999999 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.585 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.109999999999999 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.670000000000002 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.350000000000001 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.489999999999995 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.170000000000002 109.765 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.229999999999997 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.200000000000003 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.940000000000001 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 166' ' ' ILE . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.090000000000003 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.619999999999997 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' B' ' 336' ' ' ILE . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.539999999999999 108.759 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.732 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.050000000000001 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.489999999999998 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.210000000000001 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 93' ' ' ILE . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.030000000000001 109.213 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 75' ' ' HIS . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.059999999999999 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.030000000000001 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.649999999999999 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.489999999999998 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.109999999999999 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.629999999999999 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.190000000000001 110.755 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.940000000000001 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.399999999999999 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.009999999999998 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.090000000000003 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.550000000000001 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.791 HG23 ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.030000000000001 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.300000000000001 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.620000000000001 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.239999999999998 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.649999999999999 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.229999999999997 107.479 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.805 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.870000000000001 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.089 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.690000000000001 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.550000000000001 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.079999999999998 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.850000000000001 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.780000000000001 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.474 HG21 HD21 ' A' ' 26' ' ' LEU . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.8200000000000003 112.045 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.619999999999999 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.530000000000001 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.809999999999999 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.638 HD21 ' CD ' ' A' ' 145' ' ' GLU . 1.8 t-20 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.340000000000003 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.638 ' CD ' HD21 ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.079999999999998 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.880000000000003 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.219999999999999 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.350000000000001 108.772 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 152' ' ' LEU . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.350000000000001 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.672 HG11 HG12 ' A' ' 163' ' ' VAL . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.149999999999999 110.431 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.629999999999999 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.689999999999998 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.170000000000002 110.185 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG11 ' A' ' 156' ' ' VAL . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.710000000000001 109.531 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' ARG . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.649999999999999 109.831 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.403 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.109999999999999 107.192 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.786 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.6200000000000001 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 0.69999999999999996 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 0.56000000000000005 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 0.58999999999999997 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 0.5 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' B' ' 380' ' ' LEU . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 0.38 108.624 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.39000000000000001 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.44 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.34000000000000002 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28000000000000003 109.353 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.42999999999999999 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.40000000000000002 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 1.8799999999999999 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' GLU . . . . . 0.463 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.9199999999999999 110.27 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.40000000000000002 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.463 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 0.51000000000000001 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 1.7 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 0.51000000000000001 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 0.34999999999999998 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.40999999999999998 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' ILE . . . . . 0.732 HD12 ' CD2' ' A' ' 90' ' ' HIS . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 0.46000000000000002 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' THR . . . . . 0.591 HG21 ' HB ' ' A' ' 46' ' ' VAL . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 0.56000000000000005 112.02 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.48 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 0.60999999999999999 107.754 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 2.5899999999999999 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 0.27000000000000002 107.434 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.40000000000000002 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.41999999999999998 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 0.47999999999999998 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.8700000000000001 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.5 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.46 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.1600000000000001 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 0.38 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.1200000000000001 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 0.78000000000000003 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.57999999999999996 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.47999999999999998 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 0.42999999999999999 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 2.8700000000000001 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 2.6299999999999999 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 0.56000000000000005 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.55000000000000004 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 0.48999999999999999 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 0.60999999999999999 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.47999999999999998 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 0.44 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 0.51000000000000001 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 0.58999999999999997 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.63 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.68999999999999995 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.4199999999999999 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.53000000000000003 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 0.37 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.3799999999999999 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 0.23999999999999999 107.816 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' ILE . . . . . 0.513 HG21 HG21 ' A' ' 45' ' ' ILE . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.40000000000000002 110.6 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.38 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' THR . . . . . 0.442 ' HA ' HG22 ' B' ' 337' ' ' THR . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 0.46000000000000002 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.1600000000000001 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.26 109.33 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.57999999999999996 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.02 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.42999999999999999 108.535 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.4199999999999999 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 0.59999999999999998 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.4500000000000002 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 0.51000000000000001 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.1099999999999999 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 0.67000000000000004 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 0.67000000000000004 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.3599999999999999 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.1800000000000002 109.467 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 123.236 1.493 . . . . 70.849999999999994 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.822 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.6 mp -106.74 133.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 113.948 -1.478 . . . . 40.25 109.191 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -103.8 127.33 51.3 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.36 -1.291 . . . . 75.0 108.056 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mm -97.0 124.43 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.339 -2.097 . . . . 22.98 105.339 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mm -94.05 149.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 123.422 1.582 . . . . 26.309999999999999 110.319 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.75 127.4 67.47 Favored Pre-proline 0 C--N 1.276 -2.617 0 CA-C-N 114.742 -1.117 . . . . 12.15 110.672 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.5 -15.86 7.21 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.036 1.824 . . . . 15.51 110.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.03 165.36 34.92 Favored 'General case' 0 N--CA 1.517 2.907 0 N-CA-C 108.514 -0.921 . . . . 27.329999999999998 108.514 173.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -86.64 149.54 24.84 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.939 0.876 . . . . 15.16 109.027 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.73 -157.39 27.93 Favored Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.249 -1.453 . . . . 19.039999999999999 111.014 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 136.57 52.88 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.143 -1.029 . . . . 75.0 108.746 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.72 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 123.03 1.395 . . . . 20.41 109.891 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.56 158.08 43.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 114.087 -1.415 . . . . 23.309999999999999 108.38 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.72 137.1 43.81 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.412 0.625 . . . . 51.859999999999999 109.4 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.7 tt -67.12 -23.71 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 C-N-CA 118.32 -1.352 . . . . 21.989999999999998 108.249 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -73.53 -14.03 61.14 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 117.015 -1.874 . . . . 75.0 109.757 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -94.48 12.92 25.59 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.434 -1.306 . . . . 64.849999999999994 111.912 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.45 138.1 44.83 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.414 -1.328 . . . . 21.379999999999999 107.414 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -75.15 48.81 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.77 2.313 . . . . 29.27 112.195 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -151.91 115.62 4.86 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.255 -1.387 . . . . 29.02 107.255 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.39 -37.54 77.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.66 -1.216 . . . . 24.949999999999999 110.897 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.581 HG22 ' HD3' ' B' ' 338' ' ' ARG . 35.8 m -64.17 -34.19 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 115.176 -2.609 . . . . 23.739999999999998 110.504 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.52 -47.44 14.25 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.677 -1.609 . . . . 12.630000000000001 109.432 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.44 72.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.285 -0.635 . . . . 24.93 109.285 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -91.83 11.16 25.73 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 116.651 -2.019 . . . . 16.77 111.094 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER 49.69 40.58 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.914 1.384 . . . . 38.689999999999998 112.632 175.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.618 HG21 HG21 ' B' ' 372' ' ' ILE . 19.0 mm -65.05 -34.46 70.71 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 CA-C-O 123.929 1.823 . . . . 22.219999999999999 107.787 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.5 OUTLIER -87.32 -5.37 10.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 112.757 -2.019 . . . . 38.689999999999998 113.649 -175.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 135.64 -176.43 20.15 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.117 -1.993 . . . . 23.73 108.117 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -120.14 155.68 32.57 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 117.782 -1.567 . . . . 35.479999999999997 110.877 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.63 -138.24 4.75 Favored Glycine 0 N--CA 1.485 1.908 0 C-N-CA 118.889 -1.624 . . . . 18.27 110.811 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -135.63 179.38 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.617 -0.931 . . . . 27.530000000000001 108.505 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.88 160.57 29.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.828 -1.545 . . . . 26.16 106.828 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.1 mt -134.91 132.39 53.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.064 -0.717 . . . . 18.940000000000001 109.064 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -89.33 108.5 24.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 101.298 -3.593 . . . . 75.0 101.298 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -67.78 149.77 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 123.416 2.744 . . . . 15.16 114.883 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -138.2 2.22 2.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.929 -0.767 . . . . 34.869999999999997 108.929 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.32 -145.0 10.38 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.57 -1.3 . . . . 22.960000000000001 112.966 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 22.1 p30 -142.88 17.06 1.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.402 -0.469 . . . . 75.0 110.862 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.56 155.74 26.85 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.014 -2.674 . . . . 75.0 112.521 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.0 mtm -117.9 120.42 37.8 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.036 -1.438 . . . . 19.719999999999999 107.946 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -113.9 174.89 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 122.299 1.047 . . . . 16.039999999999999 110.781 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.86 126.95 93.23 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 114.274 -1.33 . . . . 21.489999999999998 109.014 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.41 -1.32 9.69 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 CA-C-N 119.536 0.87 . . . . 21.440000000000001 110.919 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 115' ' ' VAL . 23.4 m -158.85 169.2 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.729 0.776 . . . . 19.57 110.201 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.9 ' OD1' HG23 ' A' ' 115' ' ' VAL . 52.7 m-20 -85.55 128.74 34.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 103.195 -2.891 . . . . 43.469999999999999 103.195 174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 173.73 -158.45 27.53 Favored Glycine 0 C--N 1.289 -2.043 0 N-CA-C 109.429 -1.468 . . . . 30.93 109.429 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.6 m -122.14 133.98 54.74 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.733 -0.863 . . . . 18.219999999999999 110.965 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mm -68.07 137.77 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 118.125 -1.43 . . . . 30.350000000000001 107.327 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.39 -62.61 0.77 Allowed Glycine 0 C--N 1.285 -2.298 0 C-N-CA 120.423 -0.894 . . . . 27.66 111.615 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.92 142.31 30.7 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-O 124.062 1.887 . . . . 19.59 109.287 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 74.8 mt -120.96 127.55 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 104.356 -2.461 . . . . 18.07 104.356 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -64.54 144.91 56.87 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.4 -0.963 . . . . 15.949999999999999 108.4 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -63.51 -12.73 34.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.864 -0.607 . . . . 14.880000000000001 110.02 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.0 p -99.15 10.82 40.68 Favored 'General case' 0 N--CA 1.513 2.69 0 CA-C-O 122.565 1.174 . . . . 17.260000000000002 108.007 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.9 m120 47.53 42.43 14.66 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.346 -1.752 . . . . 24.440000000000001 112.525 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -124.77 -1.71 7.88 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.674 -1.211 . . . . 21.109999999999999 112.431 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -152.47 153.19 33.02 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.066 -0.654 . . . . 15.32 109.781 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -154.22 165.5 36.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 123.695 1.712 . . . . 27.109999999999999 112.497 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 t -117.99 140.35 49.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 112.461 -2.154 . . . . 19.670000000000002 109.602 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 tt -142.82 152.77 17.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.56 -1.274 . . . . 18.350000000000001 107.56 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.8 mt-10 -120.99 129.87 53.58 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.781 -2.303 . . . . 64.489999999999995 104.781 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.9 p -78.49 165.97 23.14 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 118.529 -1.268 . . . . 17.170000000000002 108.351 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -69.21 -29.98 68.05 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.907 -1.516 . . . . 59.229999999999997 106.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.45 6.45 1.81 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 123.154 0.582 . . . . 45.200000000000003 111.275 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.22 14.6 78.64 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 115.163 0.825 . . . . 24.940000000000001 115.163 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.825 HG21 HD11 ' A' ' 166' ' ' ILE . 47.3 t -94.33 135.33 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 121.005 2.403 . . . . 34.090000000000003 110.025 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -100.3 121.12 40.98 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 108.427 -0.953 . . . . 75.0 108.427 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.5 mm? -114.53 159.66 20.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.206 1.003 . . . . 49.619999999999997 110.337 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' B' ' 336' ' ' ILE . 12.8 t80 -143.52 115.39 8.26 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 122.485 1.135 . . . . 16.539999999999999 108.485 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.2 t -99.72 119.06 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.016 -1.447 . . . . 14.51 109.826 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.708 ' CD2' HD12 ' B' ' 336' ' ' ILE . 1.0 OUTLIER -121.17 107.16 12.25 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.834 0.826 . . . . 16.050000000000001 110.549 -178.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -73.95 121.32 20.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 20.489999999999998 111.551 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CE1' ' A' ' 90' ' ' HIS . . . 69.18 -176.48 30.45 Favored Glycine 0 N--CA 1.485 1.942 0 CA-C-O 122.977 1.321 . . . . 16.210000000000001 114.094 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 93' ' ' ILE . 34.2 mm -118.86 133.91 64.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 123.295 1.521 . . . . 18.030000000000001 108.653 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 55.07 24.27 5.93 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.666 -1.606 . . . . 11.08 110.697 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -17.94 64.65 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.407 0.891 . . . . 19.34 113.407 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' B' ' 335' ' ' CYS . 8.5 m -58.88 -28.09 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 O-C-N 120.18 -1.575 . . . . 19.059999999999999 109.225 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.677 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 95.7 mt-10 -64.89 -15.71 62.32 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.204 -0.998 . . . . 25.030000000000001 110.752 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.35 -1.87 47.04 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.355 -1.466 . . . . 31.649999999999999 111.279 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt 46.89 48.34 15.17 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.987 1.477 . . . . 29.489999999999998 114.987 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.2 -13.44 64.97 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.118 -1.039 . . . . 13.109999999999999 113.833 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.2 123.21 18.05 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.489 -1.007 . . . . 75.0 111.152 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.86 -6.45 60.31 Favored Glycine 0 N--CA 1.501 3.009 0 CA-C-N 116.219 -0.446 . . . . 21.629999999999999 112.494 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -117.62 154.93 30.73 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.49 0.662 . . . . 20.190000000000001 109.516 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 115.49 7.95 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.061 -1.459 . . . . 75.0 107.061 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -69.68 124.91 25.17 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.923 1.344 . . . . 30.940000000000001 108.383 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.2 mm -105.59 -36.25 3.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.02 0 C-N-CA 116.637 -2.025 . . . . 21.91 108.085 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.15 179.68 5.12 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.236 -1.386 . . . . 18.399999999999999 111.6 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.49 152.9 37.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.717 -0.614 . . . . 75.0 110.343 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 21.4 mp0 -64.32 141.75 58.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 106.806 -1.553 . . . . 75.0 106.806 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.38 -5.18 85.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.442 -1.063 . . . . 34.009999999999998 110.442 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -66.94 139.04 57.69 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 122.835 1.302 . . . . 34.090000000000003 111.225 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.1 133.2 35.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.7 m -137.88 162.04 32.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 123.564 1.649 . . . . 28.550000000000001 112.584 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -112.65 158.89 19.46 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 111.854 -2.43 . . . . 75.0 106.678 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.9 HG23 ' OD1' ' A' ' 64' ' ' ASP . 53.4 t -47.87 137.93 3.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 115.27 -0.877 . . . . 26.030000000000001 110.037 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.46 63.36 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 120.56 -0.829 . . . . 20.300000000000001 112.835 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.53 137.69 57.99 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.146 1.473 . . . . 28.620000000000001 109.236 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.7 m -77.23 133.27 38.92 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.429 1.585 . . . . 27.66 110.465 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' ILE . 51.4 t -107.8 -47.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 113.272 -1.785 . . . . 14.85 107.772 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.5 mt -148.66 143.76 18.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 122.141 0.972 . . . . 22.239999999999998 111.959 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -112.0 146.64 37.52 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 117.92 -1.512 . . . . 46.649999999999999 107.197 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 28.7 p90 -132.12 165.38 24.17 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.103 -0.953 . . . . 18.09 110.787 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -105.12 94.35 5.19 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-N 114.629 -1.169 . . . . 45.229999999999997 108.069 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.721 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 8.2 tp -55.81 -56.09 33.94 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 114.036 1.124 . . . . 14.75 114.036 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 34.5 Cg_exo -55.08 -43.97 54.03 Favored 'Trans proline' 0 C--N 1.274 -3.356 0 C-N-CA 120.519 0.813 . . . . 21.870000000000001 110.677 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -61.18 -47.62 85.33 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.914 -0.773 . . . . 31.690000000000001 108.914 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.95 -29.77 66.98 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.319 0.58 . . . . 17.550000000000001 111.477 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -67.08 -35.99 81.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.993 -1.855 . . . . 75.0 105.993 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -77.34 -42.45 36.61 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.815 -0.63 . . . . 75.0 111.287 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -95.94 -29.23 14.28 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 117.592 -1.643 . . . . 75.0 114.683 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.94 38.58 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.539 -1.264 . . . . 28.079999999999998 113.758 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -35.13 71.17 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 106.753 -1.573 . . . . 75.0 106.753 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 t -165.29 146.95 7.57 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 18.850000000000001 108.958 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.5 p -99.81 3.09 44.56 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.92 -1.037 . . . . 23.780000000000001 108.801 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.1 mt -58.51 127.28 31.36 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.074 -1.454 . . . . 11.34 107.074 177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 26' ' ' LEU . 58.4 m -118.06 103.26 50.11 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 114.101 1.148 . . . . 9.8200000000000003 114.101 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 14.8 Cg_exo -66.18 144.24 74.33 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 CA-C-O 122.017 0.757 . . . . 17.16 112.956 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.28 107.3 14.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 104.049 -2.574 . . . . 26.82 104.049 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.426 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 27.3 m -125.22 162.35 27.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 117.38 -1.728 . . . . 14.619999999999999 114.296 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -100.28 125.56 54.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.649 -2.352 . . . . 25.530000000000001 104.649 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.41 -6.35 30.76 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.226 -1.39 . . . . 28.809999999999999 111.642 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.518 HD21 ' CD ' ' A' ' 145' ' ' GLU 0.42 0.9 OUTLIER -91.85 15.3 13.28 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 127.207 2.203 . . . . 37.340000000000003 112.716 -179.127 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 81.4 mmm -36.1 -44.18 0.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.601 -1.312 . . . . 27.52 114.302 -171.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -64.96 -10.74 31.56 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 120.016 -1.678 . . . . 75.0 112.487 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.518 ' CD ' HD21 ' A' ' 142' ' ' ASN . 97.7 mt-10 -104.89 10.77 34.22 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 118.988 -2.32 . . . . 67.079999999999998 110.797 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 pt -118.51 140.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 115.921 -2.312 . . . . 40.880000000000003 113.749 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.1 tptt -76.44 -51.88 10.93 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.542 -1.208 . . . . 75.0 108.896 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -148.05 148.36 30.59 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.806 -2.357 . . . . 75.0 113.154 175.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.45 113.69 21.73 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.403 -3.09 . . . . 28.219999999999999 107.625 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 65.7 mt -110.12 112.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.012 -1.477 . . . . 51.350000000000001 107.012 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -86.51 131.5 34.16 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.715 1.245 . . . . 30.5 111.858 -177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.2 mt -96.45 177.76 5.58 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 123.011 1.386 . . . . 12.06 111.424 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.253 0.4 OUTLIER -131.14 161.34 32.33 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 112.852 -1.976 . . . . 27.16 113.724 -171.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.28 -159.36 19.35 Favored Glycine 0 N--CA 1.487 2.1 0 CA-C-O 124.02 1.9 . . . . 20.350000000000001 117.273 172.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.04 141.26 28.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.069 -2.065 . . . . 75.0 109.068 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 163' ' ' VAL . 17.7 m -129.87 159.25 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-O 123.217 1.484 . . . . 20.149999999999999 110.226 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.0 m -121.92 125.66 46.89 Favored 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 112.899 -1.955 . . . . 26.629999999999999 107.744 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -41.7 129.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 123.623 1.678 . . . . 19.16 112.556 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.47 25.42 57.97 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.611 -2.086 . . . . 17.84 113.233 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.26 -55.08 0.75 Allowed 'General case' 0 C--N 1.281 -2.402 0 C-N-CA 118.796 -1.162 . . . . 75.0 110.135 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.44 ' CG2' HG12 ' A' ' 156' ' ' VAL . 10.7 m -82.98 124.73 76.39 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 113.654 0.983 . . . . 34.689999999999998 113.654 -175.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.82 142.44 82.58 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.524 2.149 . . . . 21.170000000000002 109.921 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.605 HG12 HG11 ' A' ' 156' ' ' VAL . 34.3 m -118.71 -25.35 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 O-C-N 121.441 -0.787 . . . . 19.710000000000001 110.553 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 165' ' ' ARG . 44.4 mt -141.78 154.3 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.531 -1.285 . . . . 27.649999999999999 107.531 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.3 mtt180 -129.01 130.58 46.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 104.634 -2.358 . . . . 30.109999999999999 104.634 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.825 HD11 HG21 ' A' ' 85' ' ' VAL . 41.7 pt -128.09 157.39 40.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 C-N-CA 118.354 -1.338 . . . . 75.0 109.827 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -122.29 154.81 37.09 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.607 -1.257 . . . . 75.0 107.607 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 11.1 tttt . . . . . 0 N--CA 1.502 2.16 0 CA-C-N 115.034 -0.985 . . . . 75.0 110.396 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.179 -0.674 . . . . 3.6200000000000001 109.179 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.7 ttt -50.24 -35.34 26.4 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.776 -1.194 . . . . 0.69999999999999996 107.776 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.47 99.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.743 -0.836 . . . . 0.56000000000000005 108.743 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.49 96.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.58999999999999997 108.776 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.95 -40.28 94.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.482 -0.761 . . . . 0.5 109.062 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' LEU . . . . . 0.64 ' CD1' HD22 ' B' ' 380' ' ' LEU . 32.7 mt -62.37 -42.69 99.61 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.38 108.66 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.93 -44.31 98.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.744 -0.835 . . . . 0.39000000000000001 108.744 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.52 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.506 -0.746 . . . . 0.44 109.488 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.39 -33.92 75.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.34000000000000002 109.753 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' B' ' 341' ' ' VAL . 44.9 m-85 -75.3 -16.96 60.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 109.657 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.66 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.567 -1.413 . . . . 0.42999999999999999 109.567 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.03 170.96 19.27 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.558 -1.417 . . . . 0.40000000000000002 109.558 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -63.71 -42.67 97.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.393 -1.063 . . . . 1.8799999999999999 110.627 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 2.6 pt-20 -72.42 -16.32 61.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.391 -0.818 . . . . 2.9199999999999999 110.556 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -84.01 -3.58 58.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.841 -1.162 . . . . 0.38 109.151 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.31 118.61 39.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.245 -0.909 . . . . 0.40000000000000002 109.176 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.608 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 75.9 p -103.62 -6.45 21.63 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.755 -0.778 . . . . 0.51000000000000001 110.199 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 37.8 t-20 -168.49 157.32 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.853 -1.154 . . . . 1.7 110.679 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 93.1 mt -137.38 127.85 26.62 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.129 -0.693 . . . . 0.51000000000000001 109.129 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 55.9 t0 -167.51 160.75 13.35 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.944 -1.097 . . . . 1.01 109.052 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' ALA . . . . . 0.57 ' N ' ' OD1' ' B' ' 333' ' ' ASP . . . -161.08 -168.38 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.84 -1.162 . . . . 0.34999999999999998 110.971 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' CYS . . . . . 0.485 ' HA ' HG21 ' A' ' 96' ' ' VAL . 28.7 p -135.19 -130.92 0.16 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.387 -0.968 . . . . 0.40999999999999998 108.387 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' ILE . . . . . 0.737 HG21 ' CE1' ' A' ' 88' ' ' PHE . 4.8 mt -96.09 -35.95 6.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.515 -1.274 . . . . 0.46000000000000002 111.488 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' THR . . . . . 0.624 HG21 ' HB ' ' A' ' 46' ' ' VAL . 15.0 p -130.95 12.4 5.19 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.008 -1.058 . . . . 0.56000000000000005 111.282 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ARG . . . . . 0.581 ' HD3' HG22 ' A' ' 40' ' ' VAL . 64.4 mtm180 -133.7 137.15 45.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.87 -1.144 . . . . 2.48 110.074 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' B' ' 334' ' ' ALA . 16.0 tp -106.35 127.86 53.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.417 -0.802 . . . . 0.60999999999999999 109.458 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' ARG . . . . . 0.677 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 88.2 mtt180 -106.17 127.69 53.39 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 119.846 -0.742 . . . . 2.5899999999999999 109.33 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' B' ' 323' ' ' PHE . 55.8 t -133.54 125.53 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.298 -1.371 . . . . 0.27000000000000002 107.298 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' SER . . . . . 0.608 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 34.2 t -82.28 143.68 31.15 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.958 -1.089 . . . . 0.40000000000000002 108.916 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.44 145.42 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.281 -0.887 . . . . 0.41999999999999998 110.209 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.54 -41.74 65.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.077 -1.014 . . . . 0.47999999999999998 108.511 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' ASP . . . . . 0.461 ' HB3' ' HG3' ' B' ' 348' ' ' LYS . 2.1 m-20 -127.41 114.14 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 1.8700000000000001 109.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.31 -26.87 34.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -0.868 . . . . 0.5 109.868 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -11.8 42.66 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.798 -1.189 . . . . 1.46 110.113 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' B' ' 345' ' ' ASP . 65.3 mttt -97.32 -4.68 38.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.868 -1.145 . . . . 2.1600000000000001 110.669 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 72.8 t -74.26 131.19 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.647 -1.283 . . . . 0.38 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -90.69 90.2 7.85 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.051 -1.031 . . . . 1.1200000000000001 108.728 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -56.8 -42.33 79.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.319 -0.993 . . . . 0.78000000000000003 108.319 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.63 94.06 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.02 96.33 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.609 -1.396 . . . . 0.47999999999999998 109.609 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.6 -46.41 89.96 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.942 -1.328 . . . . 0.42999999999999999 108.842 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 15.9 mttp -55.63 -50.45 70.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.15 -0.969 . . . . 2.8700000000000001 111.864 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -59.03 -31.66 69.04 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.651 -0.656 . . . . 2.6299999999999999 109.755 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.89 4.24 2.73 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.107 -1.037 . . . . 0.56000000000000005 109.298 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.58 8.09 58.64 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.834 -1.166 . . . . 0.55000000000000004 110.472 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.03 135.79 57.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.828 -1.395 . . . . 0.48999999999999999 108.85 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.25 -26.56 56.12 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.406 -0.808 . . . . 0.60999999999999999 109.7 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -173.13 169.52 42.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.332 -1.507 . . . . 0.47999999999999998 109.332 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 77.4 t -131.29 133.88 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -1.12 . . . . 0.44 109.45 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.87 129.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-O 116.995 -1.478 . . . . 0.51000000000000001 111.49 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.65 129.03 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 121.769 2.077 . . . . 0.58999999999999997 109.916 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.2 110.7 12.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.595 -0.891 . . . . 0.63 108.595 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.74 -134.11 47.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.79 -1.724 . . . . 0.68999999999999995 108.79 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 83.2 p -90.59 -3.23 57.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -1.233 . . . . 1.4199999999999999 109.06 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -88.07 142.84 17.8 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.031 -1.628 . . . . 0.53000000000000003 109.031 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.98 133.96 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -1.107 . . . . 0.37 109.114 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -117.43 134.58 54.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.439 -0.788 . . . . 1.3799999999999999 110.064 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.72 133.76 50.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.944 -1.132 . . . . 0.23999999999999999 107.944 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 45' ' ' ILE . 75.3 mt -90.2 108.43 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.40000000000000002 109.866 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 87.8 m-85 -105.03 0.52 27.71 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.113 -1.069 . . . . 0.38 108.113 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 91.04 -162.54 28.68 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.373 -1.491 . . . . 0.38 109.373 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 45.8 p -65.31 -30.88 71.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.46000000000000002 109.308 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -69.92 4.09 2.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 2.1600000000000001 110.069 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 97.3 p -57.38 -38.45 74.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.962 . . . . 1.26 109.644 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -64.15 -25.81 68.25 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 117.14 -1.41 . . . . 0.57999999999999996 110.199 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.12 -45.54 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 121.187 1.812 . . . . 2.02 109.436 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.64 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.1 mt -60.12 -38.71 83.83 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.617 -0.883 . . . . 0.42999999999999999 108.617 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.19 -48.8 80.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.699 -0.8 . . . . 1.4199999999999999 109.331 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 35.4 m -62.61 -46.18 89.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.008 . . . . 0.59999999999999998 109.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.11 -47.27 77.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.865 -1.147 . . . . 2.4500000000000002 110.901 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.0 mtp -62.24 -39.5 93.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.08 -1.013 . . . . 0.51000000000000001 108.703 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -59.77 -46.67 88.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.487 -0.885 . . . . 1.75 108.881 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -67.85 -48.83 65.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 110.144 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.86 -43.44 98.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.12 -0.987 . . . . 0.67000000000000004 110.58 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.25 -22.46 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.67000000000000004 110.388 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -102.34 4.44 39.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.216 -0.928 . . . . 3.3599999999999999 110.362 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 C--N 1.301 -1.53 0 O-C-N 121.091 -1.006 . . . . 2.1800000000000002 109.936 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.029 -0.73 . . . . 70.849999999999994 109.029 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.783 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -105.14 133.94 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.417 -1.427 . . . . 40.25 109.689 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -103.0 123.88 47.44 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.981 -1.074 . . . . 75.0 109.473 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.7 mm -90.61 122.45 42.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 106.92 -1.511 . . . . 22.98 106.92 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 39.2 mm -89.48 148.85 4.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.703 -1.248 . . . . 26.309999999999999 110.714 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.73 126.44 57.62 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.855 -0.528 . . . . 12.15 111.192 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.25 -21.74 8.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.923 2.415 . . . . 15.51 110.796 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.561 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.88 164.77 33.51 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.201 -1.037 . . . . 27.329999999999998 108.201 175.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -84.68 153.14 23.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.124 -0.985 . . . . 15.16 109.958 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.73 -159.57 29.36 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.276 -1.44 . . . . 19.039999999999999 110.207 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.54 138.09 50.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.002 -1.11 . . . . 75.0 108.002 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mt -73.28 142.74 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.565 -1.334 . . . . 20.41 109.917 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -132.63 157.84 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.569 -0.901 . . . . 23.309999999999999 108.569 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -69.57 139.28 53.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.649 -1.282 . . . . 51.859999999999999 109.501 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.5 tt -69.97 -19.41 22.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 118.42 -1.312 . . . . 21.989999999999998 108.602 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -78.29 -10.84 59.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.059 -1.026 . . . . 75.0 109.495 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -97.3 10.48 39.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.149 -0.97 . . . . 64.849999999999994 109.803 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' A' ' 37' ' ' PRO . 2.4 t -82.63 136.25 45.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 N-CA-C 107.957 -1.127 . . . . 21.379999999999999 107.957 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 36' ' ' VAL . 29.9 Cg_endo -73.19 47.69 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.407 2.071 . . . . 29.27 113.272 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 40' ' ' VAL . 66.7 t0 -150.8 115.54 5.22 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.431 -1.322 . . . . 29.02 107.431 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.92 -36.47 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.858 -1.151 . . . . 24.949999999999999 112.756 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' B' ' 338' ' ' ARG . 35.0 m -65.13 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 119.946 -1.721 . . . . 23.739999999999998 109.399 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -81.81 -48.39 11.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.803 -1.186 . . . . 12.630000000000001 108.176 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.75 74.82 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.14 -0.975 . . . . 24.93 111.091 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -89.05 10.25 22.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.874 -1.141 . . . . 16.77 108.549 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 49.63 39.13 16.62 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.835 -0.621 . . . . 38.689999999999998 112.479 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HG21 ' B' ' 372' ' ' ILE . 15.6 mm -66.81 -32.9 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.265 -1.383 . . . . 22.219999999999999 107.265 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' HG21 ' B' ' 337' ' ' THR . 0.8 OUTLIER -89.18 1.2 7.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.376 -0.829 . . . . 38.689999999999998 111.35 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 131.4 -178.67 17.65 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.13 -1.188 . . . . 23.73 110.13 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -120.66 154.47 35.46 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.507 -1.584 . . . . 35.479999999999997 110.061 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 168.83 -142.0 7.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.524 -1.431 . . . . 18.27 109.524 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.58 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.96 -179.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.866 -1.373 . . . . 27.530000000000001 110.057 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.49 160.47 30.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.894 -1.15 . . . . 26.16 107.894 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.537 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 57.1 mt -136.61 127.03 40.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.311 -1.356 . . . . 18.940000000000001 110.826 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -83.37 108.38 12.91 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 104.082 -2.562 . . . . 75.0 104.082 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 2.7 Cg_exo -66.17 148.41 85.03 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 123.151 2.567 . . . . 15.16 116.232 -174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.3 p -140.03 0.8 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.69 -0.856 . . . . 34.869999999999997 108.69 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.41 -147.68 12.12 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.336 -1.411 . . . . 22.960000000000001 111.567 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.4 p30 -141.91 17.99 2.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.778 -0.836 . . . . 75.0 111.082 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.38 153.5 25.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.095 -1.628 . . . . 75.0 112.31 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mtm -116.18 121.3 41.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.137 -1.061 . . . . 19.719999999999999 108.137 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.72 177.3 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.664 -1.273 . . . . 16.039999999999999 110.953 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.01 127.53 90.45 Favored Pre-proline 0 N--CA 1.488 1.467 0 N-CA-C 108.617 -0.882 . . . . 21.489999999999998 108.617 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' C ' HG13 ' A' ' 63' ' ' VAL . 52.9 Cg_endo -82.8 -3.77 11.26 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.193 1.928 . . . . 21.440000000000001 111.254 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 115' ' ' VAL . 20.5 m -159.3 167.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.425 -0.797 . . . . 19.57 109.51 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.841 ' OD1' HG23 ' A' ' 115' ' ' VAL . 68.6 m-20 -83.36 124.25 30.45 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.843 -1.91 . . . . 43.469999999999999 105.843 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -178.3 -149.17 7.91 Favored Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.026 -1.559 . . . . 30.93 109.497 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 132.84 52.42 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.214 -1.168 . . . . 18.219999999999999 109.914 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.7 mm -63.86 138.76 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.378 -1.712 . . . . 30.350000000000001 106.378 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.74 -59.81 0.78 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.7 -1.714 . . . . 27.66 109.749 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 139.22 30.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.095 -1.238 . . . . 19.59 111.442 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 79.8 mt -114.85 126.96 72.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.971 -1.492 . . . . 18.07 106.971 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.5 m-85 -59.74 144.67 47.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.689 -1.257 . . . . 15.949999999999999 110.611 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.13 -14.77 40.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.382 -0.599 . . . . 14.880000000000001 109.382 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.5 p -94.05 8.39 41.65 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.341 -1.355 . . . . 17.260000000000002 107.341 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 14.4 m120 47.53 47.03 17.67 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.737 -0.665 . . . . 24.440000000000001 111.99 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.431 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.3 p-80 -129.53 -1.76 4.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.86 -1.15 . . . . 21.109999999999999 110.922 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -151.88 152.89 33.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.89 -1.131 . . . . 15.32 108.851 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -151.75 165.34 34.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.366 -1.459 . . . . 27.109999999999999 112.072 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -119.42 141.7 48.88 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.19 -0.914 . . . . 19.670000000000002 108.732 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -144.61 144.83 21.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.884 -1.135 . . . . 18.350000000000001 108.897 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.5 mt-10 -115.75 125.24 52.51 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.382 -1.34 . . . . 64.489999999999995 107.382 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.6 p -72.62 163.15 28.52 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.133 -0.98 . . . . 17.170000000000002 109.315 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.19 -25.34 63.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.771 -1.937 . . . . 59.229999999999997 105.771 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.51 -0.1 11.83 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.603 -0.726 . . . . 45.200000000000003 109.528 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.1 64.12 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.573 -1.298 . . . . 24.940000000000001 113.365 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.792 HG21 HD11 ' A' ' 166' ' ' ILE . 56.7 t -96.77 133.08 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.185 1.992 . . . . 34.090000000000003 110.097 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -98.21 121.44 40.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.948 -1.095 . . . . 75.0 109.436 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.596 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.6 mm? -111.25 162.65 14.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.944 -1.097 . . . . 49.619999999999997 109.803 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' B' ' 336' ' ' ILE . 13.3 t80 -143.49 111.19 5.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.601 -1.259 . . . . 16.539999999999999 107.601 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.3 t -97.84 126.57 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.962 -0.755 . . . . 14.51 108.962 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.845 ' CD2' HD12 ' B' ' 336' ' ' ILE . 2.0 t-80 -124.48 109.53 13.37 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.446 -0.784 . . . . 16.050000000000001 109.869 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -78.59 122.58 26.1 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.575 -1.953 . . . . 20.489999999999998 112.376 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.54 -176.98 27.06 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.596 -0.811 . . . . 16.210000000000001 111.716 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 93' ' ' ILE . 22.9 mm -117.86 133.98 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.944 -0.739 . . . . 18.030000000000001 109.56 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 84.1 m-20 57.53 24.68 10.63 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.865 -1.147 . . . . 11.08 109.757 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.24 -14.87 62.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.075 -1.016 . . . . 19.34 111.181 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' CE1' ' A' ' 75' ' ' HIS . 10.1 m -60.69 -27.55 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.219 -1.551 . . . . 19.059999999999999 109.372 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 96.1 mt-10 -65.52 -12.96 57.58 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 25.030000000000001 111.241 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.71 -5.52 58.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.72 -1.237 . . . . 31.649999999999999 108.882 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt 52.11 46.77 26.05 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.547 -0.721 . . . . 29.489999999999998 112.935 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -12.54 62.23 Favored Glycine 0 N--CA 1.506 3.358 0 O-C-N 120.554 -1.341 . . . . 13.109999999999999 114.23 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.28 123.6 19.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.262 -1.728 . . . . 75.0 111.357 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.88 -8.95 59.84 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.888 -1.149 . . . . 21.629999999999999 111.202 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -119.85 154.22 34.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.684 -1.48 . . . . 20.190000000000001 110.73 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 110.87 6.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.433 -1.321 . . . . 75.0 107.433 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.555 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -66.79 124.18 22.21 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.47 -1.394 . . . . 30.940000000000001 108.734 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.49 -33.17 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.323 -0.861 . . . . 21.91 109.939 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.41 176.78 5.57 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.416 -0.803 . . . . 18.399999999999999 109.645 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.8 156.14 31.2 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.858 -0.793 . . . . 75.0 108.858 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 32.7 mp0 -66.21 142.44 57.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.629 -1.294 . . . . 75.0 107.826 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.16 -7.43 81.5 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.676 -1.726 . . . . 34.009999999999998 109.696 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.84 135.88 53.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.131 . . . . 34.090000000000003 110.146 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.32 133.3 33.82 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.118 -1.808 . . . . 75.0 106.118 177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.26 164.54 34.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 119.93 -1.731 . . . . 28.550000000000001 112.297 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -113.62 160.12 18.91 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.695 -1.965 . . . . 75.0 105.695 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.841 HG23 ' OD1' ' A' ' 64' ' ' ASP . 58.9 t -49.12 138.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 O-C-N 121.043 -1.036 . . . . 26.030000000000001 110.599 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.69 -15.26 59.4 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.803 -1.185 . . . . 20.300000000000001 113.287 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.1 135.93 57.49 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.224 -1.75 . . . . 28.620000000000001 108.534 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.9 m -74.08 135.04 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.92 -1.112 . . . . 27.66 111.13 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.5 t -109.22 -41.96 5.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.901 -0.777 . . . . 14.85 108.901 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 119' ' ' VAL . 14.3 mt -151.1 143.46 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.373 0.606 . . . . 22.239999999999998 110.321 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -111.83 143.64 42.45 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 46.649999999999999 106.614 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.0 p90 -131.89 166.37 21.77 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 117.798 -1.561 . . . . 18.09 111.759 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -102.21 97.37 7.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.169 -1.419 . . . . 45.229999999999997 107.169 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.767 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.1 tp -55.26 -56.01 33.34 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.47 -0.769 . . . . 14.75 112.276 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 38.3 Cg_exo -56.2 -43.04 59.98 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.205 1.937 . . . . 21.870000000000001 112.657 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.019 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -66.79 -42.32 86.18 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.324 -0.86 . . . . 31.690000000000001 108.84 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -71.3 -36.54 71.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 17.550000000000001 109.982 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -61.83 -31.92 72.2 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.11 -0.994 . . . . 75.0 108.323 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -83.74 -39.15 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.647 -0.658 . . . . 75.0 111.934 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -100.51 -26.31 13.89 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.352 1.242 . . . . 75.0 114.352 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 141.04 38.43 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.108 -1.62 . . . . 28.079999999999998 111.541 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.5 -33.26 63.57 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.931 -1.137 . . . . 75.0 107.931 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.5 144.03 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.868 -0.79 . . . . 18.850000000000001 108.868 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.5 p -97.27 5.8 49.4 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.128 -0.983 . . . . 23.780000000000001 109.414 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 135' ' ' LEU . 13.8 mt -54.83 130.85 42.56 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.19 -1.411 . . . . 11.34 107.19 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 90' ' ' HIS . 52.5 m -120.06 104.94 43.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.414 -0.804 . . . . 9.8200000000000003 112.13 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 9.6 Cg_exo -69.43 138.28 38.49 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.236 1.958 . . . . 17.16 112.541 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.708 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -128.36 102.01 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 103.158 -2.905 . . . . 26.82 103.158 175.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 23.2 m -121.21 162.97 19.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.824 1.297 . . . . 14.619999999999999 112.997 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -98.86 125.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.161 -1.792 . . . . 25.530000000000001 106.161 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.8 0.27 54.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.578 -1.267 . . . . 28.809999999999999 107.578 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.615 HD21 ' CD ' ' A' ' 145' ' ' GLU . 1.5 t-20 -98.31 14.33 28.3 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.662 -1.154 . . . . 37.340000000000003 111.56 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 142' ' ' ASN . 55.5 mmm -35.01 -43.99 0.21 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.565 -1.335 . . . . 27.52 114.599 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 23.4 p-10 -68.07 -9.52 46.76 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 119.378 -2.076 . . . . 75.0 112.5 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.615 ' CD ' HD21 ' A' ' 142' ' ' ASN . 95.0 mt-10 -109.61 12.48 24.28 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.428 -1.42 . . . . 67.079999999999998 111.985 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.6 pt -121.07 137.58 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.33 -1.481 . . . . 40.880000000000003 110.308 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.8 tptt -72.78 -49.64 29.4 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.729 -0.607 . . . . 75.0 110.407 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.84 145.51 29.9 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.601 -1.64 . . . . 75.0 113.238 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.5 112.69 20.96 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.725 -1.125 . . . . 28.219999999999999 108.51 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.57 112.82 38.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 120.808 -1.183 . . . . 51.350000000000001 107.864 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -82.85 134.84 35.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.876 -1.14 . . . . 30.5 110.012 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 152' ' ' LEU . 89.8 mt -96.64 -176.43 3.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.041 -1.037 . . . . 12.06 110.641 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.52 165.58 26.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.554 -0.716 . . . . 27.16 112.794 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.24 -164.71 18.16 Favored Glycine 0 N--CA 1.49 2.241 0 CA-C-O 123.308 1.504 . . . . 20.350000000000001 114.61 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.79 144.51 25.64 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.436 -1.382 . . . . 75.0 109.088 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.668 HG11 HG12 ' A' ' 163' ' ' VAL . 16.2 m -125.79 162.19 29.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.708 -1.245 . . . . 20.149999999999999 110.139 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -121.48 122.8 40.55 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.514 -1.661 . . . . 26.629999999999999 106.514 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.1 131.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.347 1.24 . . . . 19.16 114.347 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 59.62 25.6 61.23 Favored Glycine 0 N--CA 1.501 3.016 0 O-C-N 121.741 -0.599 . . . . 17.84 112.706 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.02 -52.54 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.56 -1.553 . . . . 75.0 111.322 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 m -86.42 125.54 67.28 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.498 -0.752 . . . . 34.689999999999998 111.973 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.3 Cg_exo -64.77 142.2 75.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.934 2.423 . . . . 21.170000000000002 110.212 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.668 HG12 HG11 ' A' ' 156' ' ' VAL . 33.9 m -117.25 -26.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.835 -1.165 . . . . 19.710000000000001 109.566 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 165' ' ' ARG . 46.5 mt -140.11 152.15 21.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.228 -0.92 . . . . 27.649999999999999 109.45 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.1 mtt180 -126.82 126.7 43.82 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.597 -1.631 . . . . 30.109999999999999 106.597 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.792 HD11 HG21 ' A' ' 85' ' ' VAL . 46.7 pt -124.19 157.84 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.405 -1.434 . . . . 75.0 111.129 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.5 tttt -121.64 154.13 37.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 75.0 108.636 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.691 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.9 tttt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 120.454 -1.404 . . . . 75.0 108.793 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.091 -0.707 . . . . 3.6200000000000001 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.2 ttt -50.79 -35.59 32.73 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.933 -1.136 . . . . 0.69999999999999996 107.933 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.07 99.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.451 -0.781 . . . . 0.56000000000000005 108.913 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.29 95.87 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.878 . . . . 0.58999999999999997 108.631 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.22 94.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.09 -0.707 . . . . 0.5 109.09 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' B' ' 380' ' ' LEU . 28.3 mt -62.49 -42.86 99.78 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.625 -0.879 . . . . 0.38 108.625 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.75 -44.7 99.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.729 -0.841 . . . . 0.39000000000000001 108.729 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -63.06 -38.68 92.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.794 . . . . 0.44 109.518 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -62.08 -33.22 74.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.127 -0.983 . . . . 0.34000000000000002 109.797 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.4 m-85 -75.98 -17.75 59.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.443 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.77 -35.52 2.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.42999999999999999 109.508 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 152.69 167.61 15.67 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.9 -1.28 . . . . 0.40000000000000002 109.9 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -61.17 -42.01 97.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.67 -0.9 . . . . 1.8799999999999999 110.523 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' B' ' 327' ' ' GLU . 3.3 pt-20 -74.1 -14.52 60.99 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.359 -0.838 . . . . 2.9199999999999999 110.269 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -85.0 -3.88 58.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.936 -1.102 . . . . 0.38 108.997 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.28 118.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.908 . . . . 0.40000000000000002 109.484 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.5 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 69.6 p -104.01 -6.17 21.46 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.774 -0.77 . . . . 0.51000000000000001 110.413 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 41.4 t-20 -168.94 155.87 7.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.75 -1.219 . . . . 1.7 110.461 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 92.8 mt -136.23 127.33 27.95 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.938 -0.764 . . . . 0.51000000000000001 108.938 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -166.13 160.03 15.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.593 -1.262 . . . . 1.01 107.593 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -158.27 -165.66 1.75 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 120.67 -1.269 . . . . 0.34999999999999998 109.042 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' CYS . . . . . 0.911 ' SG ' ' P ' ' B' ' 200' ' ' PO3 . 12.8 p -144.38 -130.2 0.08 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.752 -1.203 . . . . 0.40999999999999998 107.752 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' ILE . . . . . 0.845 HD12 ' CD2' ' A' ' 90' ' ' HIS . 5.2 mt -94.98 -35.91 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 121.681 2.037 . . . . 0.46000000000000002 112.061 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' THR . . . . . 0.62 HG21 ' HB ' ' A' ' 46' ' ' VAL . 12.7 p -131.05 12.47 5.16 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.071 -1.018 . . . . 0.56000000000000005 111.039 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' ARG . . . . . 0.605 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 57.4 mtm180 -133.4 141.34 47.82 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.274 -0.97 . . . . 2.48 109.855 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.5 tp -110.49 128.58 55.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.60999999999999999 108.746 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' ARG . . . . . 0.478 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 94.7 mtt180 -106.99 126.52 52.43 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.917 -0.713 . . . . 2.5899999999999999 109.169 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.9 t -131.78 127.63 59.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.473 -1.306 . . . . 0.27000000000000002 107.473 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' SER . . . . . 0.5 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 44.6 t -85.2 144.16 28.33 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.882 -1.136 . . . . 0.40000000000000002 108.558 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.24 145.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 109.965 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -43.15 67.3 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.268 -0.973 . . . . 0.47999999999999998 108.582 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.92 115.9 20.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.451 -0.781 . . . . 1.8700000000000001 109.305 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.64 -25.13 27.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.5 109.816 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -13.46 59.55 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.759 -1.213 . . . . 1.46 109.931 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -96.83 -2.76 43.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.857 -1.152 . . . . 2.1600000000000001 110.863 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.18 132.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.413 -1.429 . . . . 0.38 108.193 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -92.23 91.42 7.73 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.017 -1.052 . . . . 1.1200000000000001 108.575 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.0 -42.52 85.37 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.345 -0.983 . . . . 0.78000000000000003 108.345 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.77 95.4 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.766 -0.827 . . . . 0.57999999999999996 108.766 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.16 98.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.677 -1.369 . . . . 0.47999999999999998 109.677 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.9 -45.96 91.47 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.916 -1.343 . . . . 0.42999999999999999 109.031 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -55.7 -47.23 77.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.374 -0.828 . . . . 2.8700000000000001 111.262 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -62.7 -31.22 72.08 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.531 -0.73 . . . . 2.6299999999999999 109.614 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' B' ' 357' ' ' LEU . 94.0 mt -71.2 3.74 3.34 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.324 -0.86 . . . . 0.56000000000000005 109.82 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 95.91 7.85 58.42 Favored Glycine 0 N--CA 1.488 2.152 0 O-C-N 120.877 -1.14 . . . . 0.55000000000000004 110.565 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 136.62 57.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.702 -1.47 . . . . 0.48999999999999999 108.568 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.06 57.0 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.327 -0.858 . . . . 0.60999999999999999 109.334 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -169.94 169.82 42.41 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.648 -1.381 . . . . 0.47999999999999998 109.648 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.0 t -131.07 133.55 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.202 -1.175 . . . . 0.44 109.382 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.35 130.48 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.166 -0.959 . . . . 0.51000000000000001 108.748 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.17 128.49 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.007 -1.058 . . . . 0.58999999999999997 110.249 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -128.07 111.39 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.52 -133.84 47.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.011 -1.636 . . . . 0.68999999999999995 109.011 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 87.0 p -90.25 -4.59 57.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.263 . . . . 1.4199999999999999 108.994 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -87.46 143.25 18.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.184 -1.567 . . . . 0.53000000000000003 109.184 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 79.0 t -121.6 133.28 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -1.087 . . . . 0.37 108.956 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -116.66 134.61 54.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 1.3799999999999999 110.178 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.4 134.81 50.92 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.948 -1.131 . . . . 0.23999999999999999 107.948 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 45' ' ' ILE . 67.9 mt -92.18 107.15 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.031 -1.043 . . . . 0.40000000000000002 110.274 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' PHE . . . . . 0.591 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 93.6 m-85 -104.72 1.77 29.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 0.38 108.89 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 90.35 -163.96 30.43 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.558 -1.417 . . . . 0.38 109.558 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' THR . . . . . . . . . . . . . 47.3 p -64.21 -30.13 71.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -1.117 . . . . 0.46000000000000002 109.918 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -70.86 5.45 1.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 2.1600000000000001 109.934 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.5 p -58.99 -35.61 73.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.472 -0.891 . . . . 1.26 109.726 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 38.0 p-10 -64.3 -29.39 70.47 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.453 -0.899 . . . . 0.57999999999999996 109.566 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' ASN . . . . . 0.432 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -64.95 -42.86 94.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.969 -1.082 . . . . 2.02 108.773 179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.6 mt -62.82 -39.41 94.21 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.547 -0.908 . . . . 0.42999999999999999 108.547 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.36 -48.51 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.417 -0.802 . . . . 1.4199999999999999 109.324 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 29.8 m -63.25 -46.45 86.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.59999999999999998 110.173 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -65.29 -45.88 82.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 2.4500000000000002 110.453 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.5 mtp -62.91 -40.83 98.79 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 108.995 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -59.12 -45.74 90.15 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.315 -0.865 . . . . 1.75 109.278 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.38 -49.82 57.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.249 -0.907 . . . . 2.1099999999999999 109.931 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -61.06 -41.81 97.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.182 -0.949 . . . . 0.67000000000000004 110.75 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 91.4 mt -71.05 -24.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.276 -0.89 . . . . 0.67000000000000004 109.971 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -100.56 3.6 42.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 3.3599999999999999 110.291 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.072 -1.017 . . . . 2.1800000000000002 109.797 -179.363 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . 0.911 ' P ' ' SG ' ' B' ' 335' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.325 0.583 . . . . 70.849999999999994 109.562 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.786 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.7 mp -104.72 133.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 40.25 109.592 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -104.29 121.74 43.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.505 -0.747 . . . . 75.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -89.5 120.99 39.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.207 -1.405 . . . . 22.98 107.207 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 36.5 mm -88.79 147.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.151 -0.968 . . . . 26.309999999999999 110.682 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.47 127.24 57.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.542 . . . . 12.15 111.152 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.52 -24.04 7.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.654 2.236 . . . . 15.51 110.431 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -147.56 164.75 32.48 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.535 -0.913 . . . . 27.329999999999998 108.535 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.0 m -84.55 153.62 23.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 15.16 109.799 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 53' ' ' LYS . . . 154.26 -160.33 29.42 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.518 -1.325 . . . . 19.039999999999999 110.425 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 137.83 50.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.24 -1.022 . . . . 75.0 108.24 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -72.56 142.01 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.837 -1.164 . . . . 20.41 109.799 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -132.66 156.4 42.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.835 -0.802 . . . . 23.309999999999999 108.835 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -68.64 138.7 55.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.943 -1.098 . . . . 51.859999999999999 109.098 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 4.4 tt -70.4 -18.88 21.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.038 -1.065 . . . . 21.989999999999998 108.756 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -79.53 -9.98 59.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.993 -1.067 . . . . 75.0 109.254 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.1 9.16 42.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.073 -1.017 . . . . 64.849999999999994 109.71 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.56 137.18 48.1 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.126 -1.065 . . . . 21.379999999999999 108.126 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -73.02 47.65 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.478 2.119 . . . . 29.27 113.064 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -151.11 116.02 5.24 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.538 -1.282 . . . . 29.02 107.538 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.97 -37.24 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.136 -0.978 . . . . 24.949999999999999 112.668 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.96 -35.49 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 119.937 -1.727 . . . . 23.739999999999998 109.489 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -81.94 -47.16 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.884 -1.135 . . . . 12.630000000000001 108.578 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.48 -37.87 79.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.419 -0.801 . . . . 24.93 110.03 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -87.61 9.13 22.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 16.77 108.889 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 50.48 38.38 18.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 116.11 -0.495 . . . . 38.689999999999998 111.952 178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.513 HG21 HG21 ' B' ' 372' ' ' ILE . 15.0 mm -67.73 -31.4 52.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.141 -1.429 . . . . 22.219999999999999 107.141 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HB ' HG21 ' B' ' 337' ' ' THR . 1.2 m -90.83 4.0 6.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.749 -0.594 . . . . 38.689999999999998 110.889 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 129.74 -177.94 17.77 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.278 -1.129 . . . . 23.73 110.278 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -121.06 153.79 36.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.732 -1.452 . . . . 35.479999999999997 109.984 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 139' ' ' VAL . . . 169.51 -141.57 6.75 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.201 -1.559 . . . . 18.27 109.201 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.7 pp -134.9 -179.87 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 27.530000000000001 109.96 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.15 160.2 30.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.888 -1.153 . . . . 26.16 107.888 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 61.2 mt -136.75 125.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.729 -1.232 . . . . 18.940000000000001 111.349 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' O ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 tmtt? -81.74 108.13 10.25 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 104.293 -2.484 . . . . 75.0 104.293 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 6.6 Cg_exo -65.81 148.61 86.66 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 123.382 2.721 . . . . 15.16 115.626 -174.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -140.72 0.62 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.612 -0.884 . . . . 34.869999999999997 108.612 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.54 -148.3 13.22 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.798 -1.191 . . . . 22.960000000000001 111.683 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 122' ' ' PHE . 23.6 p30 -142.21 17.08 2.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 75.0 111.187 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.58 153.84 27.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.13 -1.606 . . . . 75.0 111.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.3 mtm -115.66 122.06 44.42 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.044 -1.095 . . . . 19.719999999999999 108.044 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.94 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.856 -1.152 . . . . 16.039999999999999 111.064 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 127.99 88.67 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 108.701 -0.851 . . . . 21.489999999999998 108.701 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 63' ' ' VAL . 49.1 Cg_endo -82.53 -3.49 11.37 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.275 1.983 . . . . 21.440000000000001 111.427 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 115' ' ' VAL . 19.0 m -160.46 166.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.538 -0.726 . . . . 19.57 109.696 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.791 ' OD1' HG23 ' A' ' 115' ' ' VAL . 67.8 m-20 -83.39 121.52 27.27 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.746 -1.576 . . . . 43.469999999999999 106.746 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . -175.31 -146.78 5.95 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.197 -1.477 . . . . 30.93 109.974 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.4 m -127.79 130.97 49.58 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.472 -1.016 . . . . 18.219999999999999 110.178 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 67' ' ' ILE . 1.8 mm -62.82 137.7 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 106.867 -1.531 . . . . 30.350000000000001 106.867 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.48 -60.82 0.81 Allowed Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.203 -1.475 . . . . 27.66 110.508 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.58 137.87 28.68 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.893 -1.357 . . . . 19.59 110.72 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.4 mt -114.61 125.89 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.307 -1.368 . . . . 18.07 107.307 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.449 ' CE2' HG12 ' B' ' 336' ' ' ILE . 3.4 m-85 -58.56 143.09 47.24 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.942 -1.099 . . . . 15.949999999999999 110.919 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.16 -16.74 35.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.629 -0.669 . . . . 14.880000000000001 109.678 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.5 p -91.81 6.51 45.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.589 -1.263 . . . . 17.260000000000002 107.589 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' ND2' ' HD2' ' A' ' 105' ' ' ARG . 13.0 m120 47.31 50.05 14.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.771 -0.65 . . . . 24.440000000000001 111.561 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.474 ' CE1' HG12 ' A' ' 96' ' ' VAL . 10.4 p-80 -131.77 -2.2 3.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.773 -1.204 . . . . 21.109999999999999 110.489 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.585 ' CB ' HD11 ' B' ' 336' ' ' ILE . . . -153.44 152.33 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 15.32 109.015 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -151.16 165.1 34.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.558 -1.339 . . . . 27.109999999999999 111.464 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -120.01 141.23 49.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.994 -0.743 . . . . 19.670000000000002 108.994 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tt -143.26 144.26 23.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.117 -0.989 . . . . 18.350000000000001 109.464 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 96.6 mt-10 -114.79 122.75 47.33 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.93 -1.137 . . . . 64.489999999999995 107.93 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.3 p -70.88 160.68 32.37 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.379 -0.826 . . . . 17.170000000000002 109.765 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -68.34 -23.04 64.66 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.778 -1.564 . . . . 59.229999999999997 106.778 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -2.41 24.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.479 -0.563 . . . . 45.200000000000003 109.479 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.01 15.33 57.89 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.266 -0.968 . . . . 24.940000000000001 113.052 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.781 HG21 HD11 ' A' ' 166' ' ' ILE . 58.4 t -97.57 133.35 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.979 1.889 . . . . 34.090000000000003 109.831 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -98.78 120.75 39.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.855 . . . . 75.0 109.26 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.5 mm? -110.98 162.4 14.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 49.619999999999997 109.895 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' B' ' 336' ' ' ILE . 10.3 t80 -142.95 115.91 8.82 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.759 -0.83 . . . . 16.539999999999999 108.759 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.78 124.73 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.121 -0.987 . . . . 14.51 109.277 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 1.256 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.1 t-80 -120.84 105.69 10.95 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 107.562 -1.273 . . . . 16.050000000000001 107.562 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -75.26 123.88 26.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.081 -2.262 . . . . 20.489999999999998 111.438 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.43 -176.05 28.28 Favored Glycine 0 N--CA 1.49 2.256 0 CA-C-O 122.049 0.805 . . . . 16.210000000000001 111.433 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 93' ' ' ILE . 23.7 mm -118.72 133.54 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 122.061 -0.67 . . . . 18.030000000000001 109.213 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' NH2' ' B' ' 338' ' ' ARG . 81.3 m-20 57.43 26.67 12.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.249 -0.907 . . . . 11.08 109.5 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.64 -14.7 62.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 19.34 111.386 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 75' ' ' HIS . 15.6 m -61.36 -27.47 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 120.734 -1.229 . . . . 19.059999999999999 109.31 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH1' ' B' ' 340' ' ' ARG . 97.2 mt-10 -65.33 -12.95 56.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 25.030000000000001 110.759 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.98 -7.16 59.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.715 -1.24 . . . . 31.649999999999999 109.234 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 54.71 44.4 28.61 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.871 0.693 . . . . 29.489999999999998 112.871 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.27 -10.88 67.22 Favored Glycine 0 N--CA 1.504 3.167 0 O-C-N 120.691 -1.256 . . . . 13.109999999999999 113.557 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.05 124.01 20.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.324 -1.692 . . . . 75.0 110.895 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 99.48 -8.1 60.09 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.305 -0.95 . . . . 21.629999999999999 111.248 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 74' ' ' ASN . 81.9 m-85 -120.1 154.38 34.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.847 -1.384 . . . . 20.190000000000001 110.755 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 108.43 5.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.714 -1.217 . . . . 75.0 107.714 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 105' ' ' ARG . 16.7 ptm180 -64.71 122.93 18.03 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.12 -0.988 . . . . 30.940000000000001 109.066 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.6 mm -103.28 -32.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.238 -0.914 . . . . 21.91 109.628 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.31 177.25 5.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 18.399999999999999 110.211 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -120.03 156.43 30.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 75.0 109.373 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 31.2 mp0 -66.57 141.72 57.75 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.731 -1.211 . . . . 75.0 107.731 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.01 -5.26 85.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.676 -1.369 . . . . 34.009999999999998 109.676 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -68.98 135.0 50.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.252 . . . . 34.090000000000003 110.252 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -85.45 132.88 34.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.007 -1.849 . . . . 75.0 106.007 177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.29 163.39 37.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.112 -1.435 . . . . 28.550000000000001 112.484 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -113.46 160.09 18.82 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.292 -1.744 . . . . 75.0 106.292 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.791 HG23 ' OD1' ' A' ' 64' ' ' ASP . 49.2 t -50.11 136.16 8.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 O-C-N 121.158 -0.963 . . . . 26.030000000000001 110.494 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.35 59.98 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.236 -0.983 . . . . 20.300000000000001 112.669 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.53 135.05 57.52 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.226 -1.75 . . . . 28.620000000000001 108.839 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.6 m -73.04 135.86 44.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 27.66 110.845 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 120' ' ' ILE . 58.6 t -110.95 -41.16 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 14.85 108.567 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.6 mt -151.57 143.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.409 0.623 . . . . 22.239999999999998 110.1 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -112.06 142.38 44.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.424 -1.695 . . . . 46.649999999999999 106.424 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 57' ' ' ASN . 20.2 p90 -131.43 165.05 24.37 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.592 -1.317 . . . . 18.09 111.649 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 126' ' ' LEU . 9.8 t70 -100.97 96.84 7.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.479 -1.304 . . . . 45.229999999999997 107.479 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.805 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 7.0 tp -55.06 -56.25 30.11 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 14.75 112.613 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.2 Cg_exo -55.8 -42.76 63.91 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.942 1.761 . . . . 21.870000000000001 112.137 -178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.089 ' O ' HD12 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -67.49 -40.65 85.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.304 -0.872 . . . . 31.690000000000001 109.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.77 -37.63 67.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 17.550000000000001 109.621 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.87 -29.41 69.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.01 . . . . 75.0 108.754 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -87.63 -36.23 17.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.596 -0.69 . . . . 75.0 111.529 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -102.01 -26.69 13.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.77 -1.206 . . . . 75.0 113.663 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.86 39.38 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.151 -1.593 . . . . 28.079999999999998 111.758 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -33.07 64.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.885 -1.154 . . . . 75.0 107.885 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -166.66 143.57 4.84 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.858 -0.793 . . . . 18.850000000000001 108.858 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 75.8 p -96.95 4.33 51.62 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.192 -0.943 . . . . 23.780000000000001 109.43 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 135' ' ' LEU . 14.2 mt -53.52 130.95 37.49 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.548 -1.279 . . . . 11.34 107.548 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.474 HG21 HD21 ' A' ' 26' ' ' LEU . 55.1 m -120.63 105.44 41.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 9.8200000000000003 112.045 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 6.4 Cg_exo -70.68 135.47 28.33 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.581 2.187 . . . . 17.16 113.27 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.765 ' CG2' ' O ' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -125.89 99.22 5.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.465 -2.421 . . . . 26.82 104.465 175.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 30.6 m -118.03 164.65 14.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 122.591 1.186 . . . . 14.619999999999999 113.433 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.8 mp -100.64 121.29 51.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.19 -1.411 . . . . 25.530000000000001 107.19 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.93 3.52 55.01 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.083 -1.01 . . . . 28.809999999999999 108.393 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.638 HD21 ' CD ' ' A' ' 145' ' ' GLU . 1.8 t-20 -102.49 18.12 21.95 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.827 -0.624 . . . . 37.340000000000003 111.115 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.1 mmm -36.85 -43.37 0.44 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.904 1.076 . . . . 27.52 113.904 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 144' ' ' ASP . 27.6 p-10 -69.47 -8.44 46.9 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 119.829 -1.794 . . . . 75.0 112.08 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.638 ' CD ' HD21 ' A' ' 142' ' ' ASN . 93.3 mt-10 -110.68 11.76 22.68 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.278 -1.514 . . . . 67.079999999999998 111.606 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 146' ' ' ILE . 4.8 pt -120.66 137.55 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.253 -1.529 . . . . 40.880000000000003 110.335 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 168' ' ' LYS . 14.2 tptt -71.17 -50.31 34.68 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.717 . . . . 75.0 110.364 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.12 147.79 30.92 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 117.613 -1.635 . . . . 75.0 112.375 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.2 111.6 18.44 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.63 -1.168 . . . . 28.219999999999999 108.743 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.73 110.75 30.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.169 -0.957 . . . . 51.350000000000001 108.772 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -81.32 135.08 35.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 30.5 109.915 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 152' ' ' LEU . 82.6 mt -97.16 -175.0 3.11 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.361 -0.837 . . . . 12.06 110.398 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.95 166.24 25.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.078 -1.014 . . . . 27.16 111.978 -177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.85 -166.5 19.27 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-O 122.922 1.29 . . . . 20.350000000000001 113.854 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.64 147.36 23.94 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.319 -0.94 . . . . 75.0 109.103 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.672 HG11 HG12 ' A' ' 163' ' ' VAL . 16.6 m -127.27 160.64 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 20.149999999999999 110.431 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 m -120.02 121.04 38.04 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.27 -1.382 . . . . 26.629999999999999 107.27 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -37.35 131.51 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.265 1.031 . . . . 19.16 113.461 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.61 28.46 62.63 Favored Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.507 -0.77 . . . . 17.84 112.698 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 -51.54 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.486 -1.596 . . . . 75.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 m -86.59 125.43 67.29 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.335 -0.853 . . . . 34.689999999999998 112.14 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 3.5 Cg_exo -65.05 142.25 73.73 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.51 2.14 . . . . 21.170000000000002 110.185 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG11 ' A' ' 156' ' ' VAL . 34.0 m -116.65 -27.0 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.889 -1.132 . . . . 19.710000000000001 109.531 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' ARG . 48.5 mt -140.35 151.37 21.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 27.649999999999999 109.831 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.403 ' N ' HG22 ' A' ' 164' ' ' ILE . 3.7 mtt180 -126.77 124.68 40.26 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.192 -1.41 . . . . 30.109999999999999 107.192 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.786 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 46.6 pt -122.79 157.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 120.78 -1.2 . . . . 75.0 111.029 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 168' ' ' LYS . 7.9 tttt -122.08 154.16 37.7 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.176 -1.046 . . . . 75.0 108.176 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.689 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 13.3 tttt . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 75.0 109.413 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.984 -0.747 . . . . 3.6200000000000001 108.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' MET . . . . . . . . . . . . . 25.1 ttt -51.98 -36.03 48.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.068 -1.086 . . . . 0.69999999999999996 108.068 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.61 98.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.501 -0.75 . . . . 0.56000000000000005 109.051 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.32 -39.91 94.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.497 -0.927 . . . . 0.58999999999999997 108.497 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.99 94.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.09 -0.708 . . . . 0.5 109.09 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' B' ' 380' ' ' LEU . 26.3 mt -62.9 -43.24 99.34 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.624 -0.88 . . . . 0.38 108.624 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.25 -45.34 98.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.39000000000000001 108.619 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.44 109.45 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -61.61 -33.14 73.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.34000000000000002 109.87 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' PHE . . . . . 0.471 ' CE2' HG21 ' B' ' 341' ' ' VAL . 43.1 m-85 -75.94 -18.74 59.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.28000000000000003 109.353 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.35 -35.31 2.3 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.423 -1.471 . . . . 0.42999999999999999 109.423 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . 153.19 165.58 13.61 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.958 -1.257 . . . . 0.40000000000000002 109.958 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.39 -42.66 92.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.686 -0.891 . . . . 1.8799999999999999 110.151 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' GLU . . . . . 0.463 ' H ' ' HG2' ' B' ' 327' ' ' GLU . 4.6 pt-20 -74.36 -13.13 60.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 2.9199999999999999 110.27 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -85.94 -3.96 59.05 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.903 -1.123 . . . . 0.38 108.978 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.24 118.84 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.40000000000000002 109.68 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.463 ' OG1' ' OG ' ' B' ' 342' ' ' SER . 78.2 p -103.74 -6.77 21.19 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.866 -0.734 . . . . 0.51000000000000001 110.537 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' B' ' 332' ' ' LEU . 45.5 t-20 -169.02 154.3 6.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.708 -1.245 . . . . 1.7 110.41 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' B' ' 331' ' ' ASN . 94.9 mt -134.37 127.67 32.11 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.571 -0.705 . . . . 0.51000000000000001 109.217 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' B' ' 334' ' ' ALA . 59.9 t0 -165.97 161.99 17.81 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.935 -1.135 . . . . 1.01 107.935 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' B' ' 339' ' ' LEU . . . -160.04 -174.46 4.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.322 -1.486 . . . . 0.34999999999999998 109.087 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 336' ' ' ILE . 1.4 p -135.25 -131.27 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 105.317 -2.105 . . . . 0.40999999999999998 105.317 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' ILE . . . . . 0.732 HD12 ' CD2' ' A' ' 90' ' ' HIS . 7.3 mt -90.89 -35.77 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 122.622 2.465 . . . . 0.46000000000000002 111.781 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' THR . . . . . 0.591 HG21 ' HB ' ' A' ' 46' ' ' VAL . 19.5 p -129.26 11.89 5.97 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.104 -0.998 . . . . 0.56000000000000005 112.02 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' ARG . . . . . 0.74 ' NH2' ' OD1' ' A' ' 94' ' ' ASP . 62.8 mtm180 -131.22 142.96 50.25 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.186 -0.946 . . . . 2.48 109.45 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' B' ' 334' ' ' ALA . 14.3 tp -112.06 129.38 56.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.754 -1.202 . . . . 0.60999999999999999 107.754 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' ARG . . . . . 0.468 ' NH1' ' OE2' ' A' ' 97' ' ' GLU . 97.8 mtt180 -107.29 124.35 49.66 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.075 -0.713 . . . . 2.5899999999999999 109.075 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' VAL . . . . . 0.471 HG21 ' CE2' ' B' ' 323' ' ' PHE . 54.4 t -130.22 128.58 64.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.434 -1.321 . . . . 0.27000000000000002 107.434 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 330' ' ' THR . 48.1 t -86.61 144.95 26.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.935 -1.103 . . . . 0.40000000000000002 108.119 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.97 144.93 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.41999999999999998 109.841 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.9 -43.7 67.77 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.377 -0.929 . . . . 0.47999999999999998 108.733 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -125.96 117.03 22.42 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.512 -0.743 . . . . 1.8700000000000001 109.193 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.4 -23.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.5 109.81 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -15.08 62.95 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.881 -1.137 . . . . 1.46 109.668 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -96.47 -0.64 48.77 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.883 -1.136 . . . . 2.1600000000000001 111.168 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' VAL . . . . . . . . . . . . . 54.2 t -76.71 134.56 28.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.416 -1.427 . . . . 0.38 107.97 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -93.83 92.19 7.31 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.9 -1.125 . . . . 1.1200000000000001 108.647 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.88 -42.75 90.26 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.396 -0.964 . . . . 0.78000000000000003 108.396 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.16 96.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.57999999999999996 108.843 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.25 -40.62 99.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.729 -1.349 . . . . 0.47999999999999998 109.729 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.2 -45.12 94.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.005 -1.291 . . . . 0.42999999999999999 109.228 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.28 -45.44 80.17 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.856 . . . . 2.8700000000000001 110.733 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -64.25 -31.63 72.91 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.397 -0.815 . . . . 2.6299999999999999 109.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.31 2.91 4.16 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.225 -0.922 . . . . 0.56000000000000005 110.111 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 96.94 7.41 57.53 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.94 -1.124 . . . . 0.55000000000000004 110.812 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 136.26 57.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.621 -1.517 . . . . 0.48999999999999999 108.649 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.15 -30.3 60.71 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.81 . . . . 0.60999999999999999 109.545 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . -168.89 169.39 41.78 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.676 -1.369 . . . . 0.47999999999999998 109.676 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' VAL . . . . . . . . . . . . . 83.4 t -130.27 132.53 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.254 -1.145 . . . . 0.44 109.149 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 70.1 t -131.63 129.51 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.281 -1.007 . . . . 0.51000000000000001 108.281 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.26 128.03 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.998 -1.064 . . . . 0.58999999999999997 110.336 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -127.06 111.73 14.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.63 108.935 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' GLY . . . . . . . . . . . . . . . 61.37 -133.84 48.13 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.288 -1.525 . . . . 0.68999999999999995 109.288 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 89.1 p -89.6 -5.7 56.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -1.208 . . . . 1.4199999999999999 108.985 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.59 143.7 19.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.336 -1.506 . . . . 0.53000000000000003 109.336 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 74.8 t -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.386 -1.067 . . . . 0.37 108.916 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -115.62 134.74 54.76 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.52 -0.738 . . . . 1.3799999999999999 110.282 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' B' ' 373' ' ' PHE . . . -126.68 135.79 51.62 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.816 -1.179 . . . . 0.23999999999999999 107.816 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' ILE . . . . . 0.513 HG21 HG21 ' A' ' 45' ' ' ILE . 63.8 mt -93.77 105.02 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.40000000000000002 110.6 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' B' ' 371' ' ' ALA . 91.9 m-85 -102.97 2.52 35.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.367 -0.833 . . . . 0.38 109.188 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' GLY . . . . . . . . . . . . . . . 89.95 -163.81 30.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.699 -1.361 . . . . 0.38 109.699 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' THR . . . . . 0.442 ' HA ' HG22 ' B' ' 337' ' ' THR . 46.2 p -64.24 -30.35 71.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -1.081 . . . . 0.46000000000000002 110.021 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -71.25 6.65 1.6 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 2.1600000000000001 109.676 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' SER . . . . . . . . . . . . . 93.2 p -59.47 -35.82 74.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.26 109.33 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 379' ' ' ASN . 39.5 p-10 -64.19 -29.41 70.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.57999999999999996 109.695 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 378' ' ' ASP . 1.0 OUTLIER -65.75 -41.89 91.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -0.958 . . . . 2.02 108.574 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' B' ' 319' ' ' LEU . 96.4 mt -63.41 -39.85 95.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.42999999999999999 108.535 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -57.45 -48.37 79.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.383 -0.823 . . . . 1.4199999999999999 109.34 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . . . . . . . . . 26.0 m -63.8 -46.21 86.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.082 -1.011 . . . . 0.59999999999999998 110.433 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -65.86 -44.76 84.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.007 -1.058 . . . . 2.4500000000000002 110.157 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.62 -41.91 98.24 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.05 -1.031 . . . . 0.51000000000000001 109.28 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -58.28 -45.87 87.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 1.75 109.348 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -51.22 52.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -0.977 . . . . 2.1099999999999999 110.08 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -59.89 -40.78 89.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.225 -0.922 . . . . 0.67000000000000004 110.801 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . . . . . . . . . 90.2 mt -72.45 -25.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.249 -0.907 . . . . 0.67000000000000004 109.791 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -99.91 3.47 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 3.3599999999999999 109.964 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.06 . . . . 2.1800000000000002 109.467 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . 1.256 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_